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INTRODUCTION 
‘fw;w FUthf;Fk; fhjypj;j thflKk; 
gw;Wf; Nfhnyd;Nw ghpfhuk; - Kw;w 
mtd; nghWg;gy;yh nyhd;W khtjpy;iynad;Nw 
,tDzuf; fPh;j;jp ,q;F”;. 
- Neha; ehly; Neha; Kjy; ehly; ghfk; - 1 
Siddha system of medicine is being practiced from birth of our tamil language. It has 
its own lot of specialities comparing other medical systems. 
Siddha system of medical practice is considered as divine art as it lays its emphasis on 
inner soul in addition to that of external body. This system was successfully practiced 
by divine and spiritual scientists of ancient time who were known as siddhars and they 
were associated with ancient time, who were known as siddhars and they were 
associated with religion and philosophy. According to this system , man and nature 
are inseparable and interdependent. 
This system has the unique features like removal of the root cause of the disease and 
perfect remedies for the body, mind and soul. 
Siddhar‟s proposed various theories out of which the basic and important ones are, 
1. Pancha bootham theory 
2. Three humoural theory 
1. Pancha Bootham theory 
Tolkappiayam , says that the universe is formed by the five elements viz, 
earth,water, fire, air and ether. 
                  “kpfpDk; FiwapDk; Neha;nraA;k ; EhNyhh;  
        tspKjyh vz;zpa %d;W”.   
Siddha system teams the above five elements as panchabootham as every 
living organism is formed of it in definite proportions when there occurs 
changer in the proportion, it gives rise to disease 
2. The Three humoural theory 
In siddha system of medicine, the three dhosas namely vatha, pitha, kaba  
are the essential constituents of living body which are responsible for 
regulating all the body functions.             
                      “Neha;ehb Neha;Kjy; ehb mJ jzpf;Fk;  
  thae; hb thag; ;gr ; nray;”  
                                                                   --jpUtsS;th;   
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The three humours circulate in the body in different proportion‟s helps min 
digestion of foods and maintain the vitality of the body. When there is 
provocation in the ratio of humours it will disturb the normal condition and 
will result in dryness (vatham), heat(pitham), and cold (kabam). 
Siddhars view that disease may occur due to the following reasons. 
1. Derrangements of 3 humours 
2. Spiritual impacts 
3. Astrological influences 
4. Poisonous substances 
5. Psychological conditions 
Prevention and cure of illness are the basis aims of the siddha system, 
it also details with extension of life span of human being by 
administration of rejuvenators. Hence the ultimate aim of this siddha 
system of medicine is to have perfect healing of the body. 
Our sirappu maruthuvam deals with the study of 
 Yoga and kaykalpam 
 Rejuvenation therapy 
 Muppu 
 Varmam, thokkanam, enbu murivu 
 Kirigai and kanma noi 
 Dermatological disorders. 
Karappan is one of the most common skin disease encountered in medical 
practice all over the world. If it is not diagnosed early and given proper and 
adequate treatment, it may lead to chronic condition. Among the classification of 
karappan, the author have selected  karappan for the clinical study of his 
dissertation work on the basis of siddha concept on course of the disease, 
diagnosis, dietic and preventive aspects.  
Siddha system cures the disease through its drugs, prevent the progress by careful 
dieting and proper relaxation of the mind to achieve a totality of health that 
assures not only longevity but also immortlity. 
And the author hopes that this work on karappan would provide better 
information of the clinical trials with selected drugs, undertaken at Government 
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Siddha Medical College and hospital, Palayamkottai with all available sources of 
infrastructure facilities provided here. 
Drug of choice: 
1. Internal use  
Kukkiladhi chooranam 1 gm (twice a day with milk) 
2. External use 
Karappanuku ennai 
 The author has made an effort to study the disease through clinical trial and 
drug efficacy through pharmacological studies with appropriate study of 
siddha and modern aspects. 
 This dissertation is a thorough study of the disease karappan of 40 patients 
(Out-patient and In-patient) in Post Graduate Department of Sirappu 
Maruthuvam at Government Siddha Medical College, Palayamkottai 
All the patients are treated with the trial drugs and the results are dealt with. 
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AIM AND OBJECTIVE 
To give the scientific validation for kukkiladhi chooranam (Internal) and 
karappanukku ennai (external) for the treatment through phase II clinical observation 
study. 
Objectives 
Primary objective 
To evaluate the therapeutic efficacy of siddha formulation, kukkiladhi 
chooranam(interal) and karappanuku ennai (external) for karappan. 
Secondary objective 
To asses the pharmacognostical study of kukkiladhi chooranam and 
karappanuku ennai. 
To study the connection between karappan with envaigaithervu, neikuri and 
manikkadai. 
To demonstrate the prognosis of karappan using envaigaithervu, neikuri and 
manikkadai. 
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fug;ghd; 
Neha; ,ay; (Definition) 
 Njhypy; jpkph; FU> Gz;> jbg;G Mfpa FwpFzq;fis cila 
gilfis  cz;lhf;fp> mt;tplq;fspy; tPf;fk;. nfhg;Gsq;fs; fz;L my;yJ 
nrjpy; Nghd;W Njhy; RuRug;ghfp Njhypd; ,aw;if epwj;ij NtWgLj;jp rpy 
Ntis ntbg;Gz;lhf;fp ePh; frpjy; Mfpa FwpFzq;fis fhl;Lk; Njhw;gpzpia 
fug;ghd; my;yJ fug;gd; vd;W $Wth;. 
Neha; tUk; top: (Aetiology) 
 The etiological factors for karappan are as follows 
A+fp itj;jpa rpe;jhkzp 
   ‘Vohd fug;ghdpd; cw;gj;jp Nfsha; 
    Vw;wkha; khkprq;fs; Grpf;ifahYk;> 
   $ohd fk;Gjpid tuF rhik 
    nghbjhd fpoq;Ftif aUe;jyhYk;> 
   ghohd ngz; khia jd;dpw; rpf;Fk; 
    ghq;fhd tpufj;jhy; Kaw;rpahYk; 
   jhohd gz;lq;fs; rikj;Jj; jpd;dy; 
    jhf;FNk fug;ghd; jd; rhay; jhNd 
   rhayha;j; jdf;Fj; jhd; %j;j ngz;izj; 
    jhtpNdhh; jho;r;rpahq;rhjp jd;dpy; 
   fhayha;f; fye;Jz;Nlhh; fyfk; nra;Njhh; 
    fw;Gila kq;ifaiuf; fUjpNdhh;fs; 
   thayha; tho; kuj;ij ntl;bNdhh;fs; 
    kUj;jth;fs; tz;zhh; ehtpjh;fs; $ypf; 
   $ayha;f; nfhlh Njhh;fs; FUepe;jpj;j 
    nfhLk;ghtp fug;ghdpw; Fwpf; nfhs;thNu” 
       -A+fp itj;jpa rpe;jhkzp 
           (fug;ghd; Nuhf epjhdk;) 
 Excessive intake of fish, meat, cereals like ragi, maize, rhizomes. 
 Anti social activities which ultimately end in psychic disturbances leads to 
Karappan disease. 
rpj;j kUj;Jtk; rpwg;G 
  ‘ngUFQ; Nrhs kpWFk; ngUq;fk;g 
   tuF fhUld; thioapd; fhNahL 
  ciunfhs; ghfy; nfspw;W kPd; cz;bby; 
   tphpt jha;f;fug; ghDkp Fe;jNj” 
      - rpj;j kUj;Jtk; rpwg;G 
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 This poem specifies the dietary relations with the karappan disease. 
 Bitter gourd, ragi, maize, unriped banana, fish items aggravates the disease. 
FUehb E}y; 
  ‘rq;ifapy; tp\ fug;ghd; tUkhNwJ 
   rhuKld; fpUkp tpOe;jd;ikNaJ 
  cl;bzNk mjpfk; tUkpe;jphpa Nghfj;jh 
   YoWJUfp aj;jpapNyNtT nfhz;L  
  el;lzkha; nte;j njhU kr;ir jd;dpy; 
   ehl;lkpl;l fpUkpaJaZFk; NghJ 
  kl;LlNd fpUkpnay;yhk; gwe;jq;Nfwp 
   tifAlNd khq;fp\j;ijj; Jisj;J NkTk;” 
  ‘jpl;lKld; tpl fug;ghd; gwe;J NkNy 
   jpdTlNd guguj;Jr; nrhwpAz;lhNk 
  gay;nkhopaph; Njfj;jpy; fpUkpjhNd 
   gue;JVtp Fl;lk;Nghy; Gs;spfhZk; 
  kayJTq; fpUkpAe;jhd; ele;J Gf;fpy; 
   NkdpaJ ruruntd ntbj;Jg; Gz;zhw; 
  fay; ngUFk; Foy; kltPh; nrhy;yf; Nfsph; 
   fufuj;Jr; nrhwp ngUFq; fug;ghd; jhNd” 
         -FU ehb E}y; 
 Excessive Sexual indulgence aggravates Azhal thathu which inturn affects the 
“Kozhupphu” and “Thasai” of the seven udal kattugal. 
 The micro organisms enter through these affected thathus and cause the 
disease Karappan. 
 guuhr Nrfuk;........ rpuNuhf gFjp 
   ‘thjgpj;jq; fgkpit %d;wth; 
    NwJ thy;ntsp thy;kpb ahtpdh; 
   Nfhij ahuba ghh;itah; thw;Fsph; 
    Ngj ephpit ahYd NgRNfs; 
   Ntff; fhw;wjpdh; gid nty;yj;jhy; 
    ghf kpf;fyhd; Nkjpg; ghnta;ayhy; 
   jhfkhdp tUf;f jprhh;jyhy; 
    Nghf thio tOjiy Ks;spf;fha; 
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fhAk; gy;yplj; jhw;fuj; jhw;fspy; 
    vAk; tz;nlyp ahy;tUNk Jntsp 
   Fb ey;ywpthd vUtpdhh; 
    ad khd fug;ghd; tiffNs” 
      -guuhr Nrfuk; ........... rpuNuhf gFjp 
 Living in torrid climate and cold weather 
 Drinking contaminated water 
 Airborne infection 
 Excessive intake of palm jaggery and brinjals, plantain etc., 
 Poisonous bites are the factors. 
Neha; vz; (Classification) 
 ‘vz;gJ fug;ghd; jd;id apak;gpLkW NfsPh; 
  ez;gpLk; thjk; gpj;jk; eyk;nfl;Lj;jhdk; tPq;Fk; 
 Gz;gLk; fuq;fs; re;J Giye;Jly; fLj;J NehFk; 
  td;ikAld; ntbj;J #iy tUtJ uzkPnjd;Nd” 
- mfj;jpah; uz E}y; 
It was mentioned that karappan was classified into 80 types. 
 mfj;jpah; 2000 
 ‘tpsk;gpL thjNehT vz;gJ ehYkpff; 
  cs;sq;fs; rd;dp Kg;gNjhq;Fly; thAnkl;L 
 foq;fK Kg;gj;njO fug;gD kWgj;jhW 
  jdq;nfhs;spg;GUjp ehY rhw;Wis Fwitnal;Nl” 
- mfj;jpah; 2000 
Karappan are 66 in numbers. But the names were not given. 
 A+fp itj;jpa rpe;jhkzp 
 ‘Mnkd;w fug;ghd;jhd; VOtpjkhFk; 
  mlq;fhj thjj;jpd; fug;ghNdhL 
 fhnkd;w fz;lkhq; fug;ghdhFk; 
  fUfpa Njhh; twl;rpahq; fug;ghNdhL 
 Njnkd;w jpkph;thj fug;ghd;  ehYk; 
  rpurpdpNy ngUq; fghyf; fug;ghd; 
 Nfhnd;w gpj;jkhq; fug;ghNdhL 
  nghpa Nrl;Lkf; fug;ghd; ngah;jhNd” 
- A+fp itj;jpa rpe;jhkzp 
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1. thj fug;ghd; 
2. gpj;j fug;ghd; 
3. fg fug;ghd; 
4. jpkph;thj fug;ghd; 
5. fz;l fug;ghd; 
6. fghyf; fug;ghd; 
7. twl;rp fug;ghd; 
 nrfuhrNrfu itj;jpak; 
 ‘nrg;Gthjf;fug;gd; Nrh;tul;rpf;fug;gd; 
  ntg;GWk;ngUq;fug;gd; tpuw;wpkph;thjnkd;Dk; 
 fg;GWfug;gNdhL fghyj;jpw;Nrh;fug;gd; 
  jg;GWtp\ghfj;jpw; rhh;e;jpLq;fug;gdhNk> 
 fug;gWilfug;gd; fue;Jnfz;ilf;fug;gd; 
  Jug;GWnrhwpfug;gd; J}q;fpLfug;ghNdhL 
 epug;gptPq;Ff;fug;gd; ePz;bLntbf;fug;gd; 
  mhpg;GWfug;ghNdhL mlh;fhzhf;fbf;fug;gd; 
 fbj;jpLnrq;fug;gd; fUJ%yf;fug;gd; 
  mLj;jRFzpfug;gd; mow;Wnfhs;spf;fug;gd; 
 Jbj;jnfhg;Gsf;fug;gd; Njhd;Wfz;lf;fug;gd; 
  neLj;jfw;fug;gNdhL ePs;nghj;jpf;fug;ghdhNk 
 MFq;fhjpw;fug;g dhkpUgj;J %d;wpy; 
  thFWFzq;fNshL kUtpLkUe;JQ;rpq;ifr; 
 NrfuhhpaNfhdhd NrfuhrNrfud;wd; 
  XifNrh;e;jpLtjw;fh Ayfpdh;f;Fiuj;jjhNk”. 
- NrfuhrNrfu itj;jpak; 
 
1. thj fug;ghd; 13. mhp fug;ghd; 
2. twl;rp fug;ghd; 14. fhzhf;fb fug;ghd; 
3. ngUq;fug;ghd; 15. nrq; fug;ghd; 
4. jpkph;thj fug;ghd; 16 %y fug;ghd; 
5. fghyf; fug;ghd; 17. mRFzp fug;ghd; 
6. tp\ghf fug;ghd; 18. nfhs;sp fug;ghd; 
7. Gil fug;ghd; 19. nfhg;Gs fug;ghd; 
8. nfhz;ilf;fug;ghd; 20. fz;l fug;ghd; 
9. nrhwp fug;ghd; 21. fw; fug;ghd; 
10. J}q;F fug;ghd; 22. nghjp fug;ghd; 
11. tPq;Ff; fug;ghd; 23 fhjpw; fug;ghd; 
12. ntb fug;ghd;   
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FU ehb rh];jpu E}y; 
Karappan was classified in to 85 types 
‘gLtd; Kg;gj;jpuz;L gUnthU ehw;gj;njhd;W 
 KLfpLk; tp\gkhW Kw;W NthGrp %d;We; 
jpLf;fpLk; gPyp %d;W rpurpdpw; rpye;jp nrhy;ypy; 
 fLfpLik gj;jhW fug;ghd; nkd;gj;ije;J”. 
- FU ehb rh];jpu E}y; 
 
,uj;jpd RUf;f ehb E}y; 
Karappan was classified into 90 types 
   ‘ehslh ehw;gJ ehY E}W 
    eaKlnd ehw;gj;J vl;LNuhFk; 
   ghug;gh thjkJ vz;gj;J ehY 
    gUf;fNt gpj;jkJ ehw;gj;J vl;L 
   jhug;gh Nrj;Jkq;fs; njhz;Z}w;whW 
    gPypAlDW trpa kQ;rjhFk; 
   nghhpfug;ghd; njhd;D}W nfz;ilgj;J” 
       -,uj;jpd RUf;f ehb E}y; 
 
gjpnzd; rpj;jh; ghythfl jpul;L 
Karappan was classified into 18 types 
   ‘nrq;fug;ghd; mdy; fug;ghd; jhDk; kz;ilr; 
    rpuq;Fgz;Zk; mhpfug;ghd; nghhpf ug;ghd; 
   mq;fkjp nyOfug;ghd; jhDkpf;f 
    msuhk;cjp uf;fug;ghd; fl;b NahL 
   nghq;fkha; tPq;fp fug;gh De;jhd; 
    Gfyhpa rl;iljb ntbf ug;ghd; 
   rpq;fKf vhpf;fug;ghd; thj gpj;jr; 
    Nrj;kNjhl fug;ghd; gjpndl;lhNk” 
      -gjpnzd; rpj;jh; ghythfl jpul;L 
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1. thj fug;ghd; 13. nfhs;sp fug;ghd; 
2. gpj;j fug;ghd; 14. Njhl fug;ghd; 
3. fg fug;ghd; 15. thiy fug;ghd; 
4. mhp fug;ghd; 16 tws; fug;ghd; 
5. XL fug;ghd; 17. tPq;F fug;ghd; 
6. #iy fug;ghd; 18. nrq; fug;ghd; 
7. ntb fug;ghd;   
8. kz;ilf; fug;ghd;   
9. rl;ilf; fug;ghd;   
10. CJ fug;ghd;   
11. fUq; fug;ghd;   
12. nghhp fug;ghd;   
Nkw;$wpa tiffs; ghyh;fspy; fhzg;gLfpwJ. 
fug;ghd; Nehapd; nghJf; FwpFzq;fs;: 
(General Signs and Symptoms) 
  ‘vz;gJ fug;ghd; jd;ikapak;gpL khW Nfsph; 
   ez;gpLk; thjk; gpj;jk; eyk;nfl;Lj; jhdk; tPq;Fk; 
  Gz;gLq; fug;ghd; re;J Giye;Jly; fLj;J NehFk; 
   td;ikAld; Nntbj;Jr; #iy tUtJ uzkPnjd;Nd” 
  ‘cidQ;RNk tapWjhd; rPjq;fhZk; 
   c\;zkha; %j;jpue;jh KUq;fp tPOk; 
  midQ;RNk aq;fnky;yhk; nrhhpAz;lhk; 
   moyhf ntJk;gyha;f; fhf;ffhNyhAk; 
  GifQ;rNkdp ypq;fj;jpw; Gz;NghY Uf;fpg; 
   nghbg;nghbaha; Rz;zhk;Gf; fw;Nghy; tPOk; 
  fisQ;RNk ePNuhL kyKq;rpf;Fk; 
   frpANk fug;Nghdhk;” 
        - mfj;jpah; tpuzE}y; 
 Swelling in the affected areas. 
 Body temperature raises 
 Appearances of papules, vesicles which burst leads to ulcer formation 
 Oozing from the lesion 
 Itching all over the body. 
 Scanty micturition and Constipation. 
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thj fug;ghd; nghJf; FwpFzq;fs; 
 nrfuuhrNrfu itj;jpak; 
  ‘clk;ngyhk; ntJk;gpnehe;J cise;Jfhy;re;Jiff 
   splq;fspw;Rue;J tPq;fp apUe;J gpd; Dth jpahfp 
  Klq;fpNa tuz;L Njhd;wp Kw;wpNa ntbj;Jg; Gz;zhk; 
   ,lq;nfhlhf;fug;gd; thj Fzkpnjd; wpak;gyhNk” 
 Mild fever 
 Swelling in the joints of hands and leg 
 Dry skin 
 Formation of ulcers. 
  ‘re;Jjhs;nkhopnghUj;Jj; jhdq;fSise;JtPq;fp 
   te;Jjhd;Gz;Nghw;fhak; tUe;jjpNaapUe;Jthb 
  nehe;Jjhd;fdj;Jtw;wp NehTld; nrhwpAz;lhFk; 
   ,e;j Neha;jhDk;thj fug;gndd;wpak;gyhNk.” 
 Acute pain in joints 
 Body ache and swelling 
 Fever 
 Immobility 
  ‘,Ue;njOe;jpUf;Fk;NghJ kpaw;Wq;fhy;fuq;fs; re;J 
   tUe;jplj;jpkph;j;JtPq;fp tuz;bby;ntbj;Jg;Gz;zhk; 
  jpUe;jpatq;fe;jhDk; nrakwg;nghUKkhfpy; 
   tUe;Jkpf;Fzq;fs; fz;lhy; thjhkhq;fug;gdhNk.” 
 Dryness of the joints 
 Immobility 
  ‘nehe;Jfd;wpajyj;jpy; NehTilGz;fs;jd;dpy; 
   te;Jty;yhAjq;fs; tYTwj;ijj;jlj;jpy; 
  re;Jjhs;nkhopnghUj;Jj; jhdq;fsjpNyahfpy; 
   te;Jjhd; njhLf;Fnka;apy; thjkhq;fug;gdhNk.” 
 Formation of vesicles and pustules 
 Lesions present in upper and lower limbs. 
 ‘fz;Ze;J}q;fpeLTe;jp fdj;Jr;Rue;J ntJk;GKly; 
  ez;Ze;JilAq;fdjpkpuha;iee;NjjiyAq; fpWfpWf;Fk; 
 kz;zpw;gpwe;Njhh; jq;fsplk; te;NjtUe;jkaf;fpLfpy; 
  vz;zpthjfug;gndd ,JTk; Ngryhnkd;whh;” 
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 Headache 
 Slight fever 
 Giddiness 
 Tiredness 
 ‘tPq;Fq;Fj;Jk;kpfTisAk; tplhkw;wpkph;j;JtPq;fp epw;Fk; 
  Vq;fg; Gz;zpw;ryk; tpOj ypJTe;jpdT nrhwpT nra;Ak; 
 ePq;fpr; nrt;NtjPuhJ neLehl;gl;Nl krfpepw;Fk; 
  Njq;fr; Rl;Lg;Gifj;J tplj; jpUk;thjfug;gdpNj.” 
       -nrfuhrNrfu itj;jpak; 
 Lesions starts at dry vesicles 
 Oozing 
 Itching 
 The body temperature raises 
 The lesion starts as dry vesicles and later becomes exudative in nature leading 
to ulcers formation with secondary infection. 
 The lesion are highly itching in nature 
 Pain and swelling in the affected areas of flexures of upper and lower limbs 
(like wrist Knee, ankle joints, etc.) 
 Difficulty in walking due to swelling in the joints. 
 In severe cases extreme drowsiness, oedema of lower abdomen. 
 The lesion show recurrence and come on and off. 
 A+fp Kdp itj;jpa rpe;jhkzp: 
  ‘nfhs;sNt clk;ngy;yhk; ntJk;gha; nehe;J 
   File;JNk kpfr; Rue;J tPf;fkhFk; 
  tps;sNt Njfnky;yhk; Gz;Nghy; nehe;J 
   ntbj;JNk Gz;zhFk; tpuy;fs; re;J 
  Ks;sNt Klq;fpNa euk;G fhZk; 
   nkhopfs; gf;fkpf;f ,lkpf cyh;e;J 
  ks;sNt NkdpaJ tuz;L fhZk; 
   thjkhq; fug;ghd;wd; td;ikjhNd.” 
     -A+fpKdp itj;jpa rpe;jhkzp 
 gjpnzd; rpj;jh; ghythfl jpul;L: 
 njwpf;Fk; tpq;FKl nyq;F Nkjpkph; fLg;gjhfpaOe; NjfNkw; 
  nghwpg; gwe;jnjdNt Gz;zhfpajp Nyntbj;jjpf nghq;fkha; 
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 KWf;fpna Rukjhfp ehtJ twz;L NehaJ Kjph;e;jpby; 
  ntwpf; fUq;Foyp khJthj fug;ghnddg; Gfy;th;Nktpl” 
      -gjpnzd; rpj;jh; ghythfl jpul;L 
 
mfj;jpah; MAh;Ntjk;: 
‘clk;ngy;yhk; ntJk;gp nehe;J Tiye;J fhy;iffs; jhD 
 kplq;nfhz;L fue;J tpq;fpapUg;gpDe; jhifahNy 
Klq;fpNa tuz;L jhD Kw;wpNa ntbj;Jg; Gz;zh 
 kplq;nfhlh fug;ghd; thjnkd;W jhdpak;g yhNk” 
‘,Ue;njOe;jpUf;Fk; NghJ tpw;Wf;fhy ah;e;jah;e;J 
 cUj;jplj; jpkph;e;J tpq;fp tuz;Lld; ntbj;J Gz;zhe; 
jpUe;jpatq; fe;jhDQ; nrakwg; nghUKkhfpy; 
 tUe;jpu kpf;Fzq;fs; fz;lhy; thjkhq; fug;gdhNk” 
‘nehe;Jgpd; fz;zpy; kpf;f NehTil fze;jd;dpy; 
 te;J ty;yhAjq;fs; tLg;Guj;ij kw;wNghJ 
re;Jjhd; nkhspnghUe;J jirT jhdq;fshfpy; 
 te;Jjhd; nfLf;Fk; thjfug;ghndd;wwpayhNk” 
‘tPq;Fq;Fj;J kpfr; rpuKk; tplhkw;wpkph;e;J tpjdpf;F 
 khq;fjpw; ryk; tpOe;jhyJ Te;jpdthar; nrhhp nra;apy; 
ePq;fpr; nry;yj; jPuhJ neLehl;glNt tp\kpf;Fe; 
 Njq;f Gijj;Jr; Rl;L tplj;jPUk; thj fug;ghdpNj” 
‘re;J fhy;nkhsp nghUe;Je; jhdq;fSise;J tPq;fp 
 te;Jjhd; Gz;Nghw; fhAk; tUe;jpNa apUe;J thLk; 
nehe;J jhdpw;f nthl;l NehAld; ntg;gj; Njhd;W 
 kpe;j Neha; tUfpy; thj fug;gndd;wwpayhNk” 
      -mfj;jpah; MAs;Ntjk; 
 Njiuah; mUsp nra;j Nehapd; rhuk; 
  ‘,ak;Ge; jpkph; fha;r;rnyq;Fk; tPf;fj; jpul;rp 
   jaq;fq; fZj; NjhWe; jhd; fLg;ghk; gad;glNt 
  te;tiuf; fzj;jpy; thJ fug;ghd; td;if 
   nre;jhkiu Kfj;jha; nrg;G” 
     -Njiuah; mUsp nra;j Nehapd; rhuk; 
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rpj;jh; mWit kUj;Jtk;: 
‘vd;dTiu thj rpuj; NjhAq;fu g;gdJ 
 kpd;Dk; Kfj;jhd; tPq;F nka;FspUk; Ntjidahk; 
gpd;dhd re;JlNd gplhp Kj yhkplq;fs; 
 mwpNa ePUQ; ryKk; gha;e;jdy; Nghnyhpe;J Fj;Jz;lhk; 
nrhwpAk; gpd;dh; kpff; fha;e;J JQ;R nea; Nghw; fope;NjhLk; 
 gwpAk; nghUf;F rhk;gundg; ghpa ehWk; Gydhw;Wk; 
FwpNa thj rpu fug;ghd; nfhz;lhh; Fw;w FzkpitNa” 
     -guuhrNrfuk; - rpuNuhf epjhdk; 
gpj;j fug;ghd; 
  ‘jhdhff; fz;J}q;fp eLT ce;jp 
   jsh;e;JNk cl;fhh;e;J ntJg;Gz;lhFk; 
  J}zhff; fpWfpWf;F KlyhQ; NrhUk; 
   nrhhpe;JNk clk;G kQ;rspf;Fk; 
  Ntzhf tz;zj;ij ,wq;nfl;lhJ 
   kpLf;fhd jPgke; jpj;Jg; NghFk; 
  Ngdhf CUtJ Nghyf; fhZk; 
   gpj;j fug;ghd; Fzj;jpd; ntw;wpahNk” 
      -A+fp itj;jpa rpe;jhkzp 
Nrj;Jk fug;ghd; 
  ‘ngw;wpaha;r; rhPukJ ntspwpf; fhZk; 
   Ngr;Rj;jhd; fk;kyha; jhdpUf;Fk; 
  Gj;jpaha; thh;j;ijaJ nghWf;fpr; nrhy;Yk; 
   gpugye;jhd;  kpfg;Ngrp %r;Rz;lhFk; 
  vj;jpaha;r; rfyiuANkty; nfhs;Sk; 
   <isapUky; %r;Rf; fhjpiur;ry; 
  Kj;jpaha; Nkhl;r top KiwikahFk; 
   Kjph; Nrl;gf; fug;ghdpd; %h;f;fe;jhNd” 
      -A+fp itj;jpa rpe;jhkzp 
fghy fug;ghd;: 
  ‘fhzNt fhnjy;yhk; jpdTz;lhFk; 
   fz; jpdthk; fz;le;jhd; fufuf;Fk; 
  G+zNt fz;zPUk; gPisAz;lhk; 
   Ngr;Rke;j %f;fjdpy; ePNughAk; 
  NjhzNt rpuRjdpw; nrhhpjYz;lhw; 
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   Jk;ky; kpfTz;lhFe; Jbf;Fk; new;wp 
  MzNt mz;zhf;fp oYz;lhFk; 
   moq;fhj fghy fug;ghd;wd; FzkhNk.” 
      -A+fp itj;jpa rpe;jhkzp 
 
fz;l fug;ghd;: 
  ‘jspuhfr; rpunkq;F kpff; fdj;Jj; 
   jiyfhJ kz;nlay;yhe; jbj;J NehFk; 
  espuhf tUj;jp tpf;Fk; ehj;jbf;Fk; 
   eykhd clk;Gjdpw; nrhhpAkhFk; 
  Fspuhff; Fspe;jJNk kaph;f;$r;rhFk; 
   $g;gpl;lhy; kpfg;gaf;Fk; $rq;fz;jhd; 
  fspuhf Kl;Nghyf; fz;le;jd;dpy; 
   fufuf;Fk; fz;lkhq; fug;gdhNk.” 
      -A+fp itj;jpa rpe;jhkzp 
twl;rp fug;ghd;: 
  ‘fz;lkha; kpftPq;Fk; Fj;jYz;lhk; 
   fdkhf clk;ngq;Fk; kpfNt CWk; 
  Jz;lkhAly; gijj;Jr; nrhwpjYz;lhk; 
   NrhUnk nae;Neuk; kaf;fj;jhNy 
  tz;lfe;jhdpy;yhk Ylk;G tw;Wk; 
   khWghlha;g; gpjw;wp kWFk; thh;j;ij 
  gpz;lkhf;fp le;Jz;L GyhNy ehWk; 
   ngUtwl;rp fug;ghd;wd; NghpjhNk” 
      -A+fp itj;jpa rpe;jhkzp 
jphph;thj fug;ghd;: 
  ‘tz;ikah Al;fhh;e;J vOk;Gk; NghJ 
   tUj;jkha; fhy;iffsp ypLg;Gr; re;J 
  jpz;ikaha;j; jpkph;j;jJNk fuL fl;Lk; 
   nraypoe;J tPq;fpNa ntbj;Jg; Gz;zhFk; 
  jd;ikaha;r; rlnkq;F KjyhFk; 
   jz;zPh;jhd; kpff;fLj;Jj; jdpr; #Lz;lhk; 
  cz;ikaha; Nkdpnaq;Fk; cisr; rYz;lhk; 
   cjWNk jpkphpthjf; fug;ghDNk. 
      -A+fp itj;jpa rpe;jhkzp 
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Prognosis of Karappan (rhj;jpak;-mrhj;jpak;) 
  ‘%h;f;fkhk; rhj;jpaij nkhopaf; Nfsha; 
   nkhopfpd;w thj fug;ghd; wd;NdhL 
  Ch;f;fkhk; gpj;j fug;ghDkh Fk; 
   cah;fpd;w twl;rpahq; fghyf; fug;ghd; 
  jh;f;fkh apJehYQ; rhj;jpakhk; 
   jSf;fhd jpkph;thjf; fug;ghd; fz;lk; 
  ePh;f;fkhQ; Nrl;g fug;ghd;wd; NdhL 
   nrg;gpaNjhh; ,J %d;Wk; mrhj;jpakhNk” 
      -a+fp itj;jpa rpe;jhkzp 
rhj;jpak;: 
1. thj fug;ghd; 
2. gpj;j fug;ghd; 
3. twl;rp fug;ghd; 
4. fghy fug;ghd; 
mrhj;jpak;;: 
1. jpkph;thj fug;ghd; 
2. fz;l fug;ghd; 
3. Nrj;Jk fug;ghd; 
Neha; fzpg;G 
 gpzpawp Kiwik 
 ‘gpzpawp Kiwik” vd;gJ cliyg; gw;wpa Nehiaj; njhpe;J 
nfhs;Sfpw xOf;fk; vdg;gLk;. 
1. nghwpahw;Nwh;jy; 
2. Gydhywpjy; 
3. tpdhjy; 
1. nghwp: 
 %f;F> tha;> fz;> Njhy;> nka;> nrtp vd Itifg;gLk;. 
2. Gyd;: 
 ehw;wk; (kzk;)> Rit> xsp> CW> Xir vd Itifg;gLk;. 
3. tpdhjy;: 
 gpzpAw;wtiug; gw;wp mwpa Ntz;batw;iw gpzpahspiaf; nfhz;Nlh 
my;yJ mth; Rw;wj;jhiuf; nfhz;Nlh mwpe;J gpzpiiaf; fzpj;jiyf; 
Fwpf;Fk;. 
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vz;tifj; Njh;T: 
   ‘ehbg;ghprk; ehepwk; nkhoptpop 
   kyk; %j;jpukpit kUj;jtuhAjk;” 
    - Neha; ehly; Neha; Kjy; ehly; (Kjy; ghfk;) 
 vz;tifj; Njh;Tfshdit kUj;Jth; gpzpia fzpj;jwpa cjTk; 
fUtpfshFk;. 
  ‘ePba tpopapdhYk; epd;wp ehf;Fwpg;gpdhYk; 
  thba NkdpapdhYk; kynkhL ePhpdhYk; 
  $ba tpahjp jd;idr;Rfk; ngw mwpe;J nrhy;Ny” 
       -mfj;jpah; itj;jpa ty;yhjp 600 
vz;tifj; Njh;Tfs;: 
1. ehb 
2. ];ghprk; 
3. eh 
4. epwk; 
5. nkhop 
6. tpop 
7. kyk; 
8. %j;jpuk; 
1. ehb (Pulse) 
 vz;tifj; Njh;Tfspy; kpf El;gKk;> Kf;fpaKk; tha;e;jJ. 
 ehb vd;why; clypy; caph; jhpj;jpUg;gjw;Ff; fhuzkhd rf;jp vd;W 
$wg;gLfpwJ. 
 jr ehbfspy; Kf;fpakhdit ,lfiy> gpq;fiy> RopKid> ,it 
%d;Wk; KiwNa mghdd;> gpuhzd;> rkhdd; vd;w thAf;fspd; 
$l;Lwthy; njhopy; GhpAk; NghJ cah;j;jhJ Njhd;WfpwJ. 
  ,lfliy + mghdd; - thjk; (thAtpd; $W) 
  gpq;fiy + gpuhzd; - gpj;jk; (NjAtpd; $W) 
  RopKid + rkhdd; - fgk; (mg;Gtpd; $W) 
 ehb ngz;fSf;F ,lf;ifapYk;> Mz;fSf;F tyf;ifapYk; ghh;f;f 
Ntz;Lk;. ngz;fSf;F ehgpf;$h;kk; Nky;Nehf;fpAk; Mz;fSf;F 
fPo;Nehf;fpAk; ,Ug;gNj fhuzk;. 
ehb ghh;f;Fkplq;fs;: (Location of pulses) 
 ‘jhJKiwNfs; jdpj;jFjpr; re;jpNjhL 
  XJW fhkpa Ke;jp neL khh;G 
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 fhJ neL%f;Ff; fz;lk; fuk; GUtk; 
  NghJWKr;rp Gfo; gj;Jk; ghh;j;jpNl” 
     -jpU%yh; ehb E}y; 
  Nkw;$wpa ,lq;fspy; ehb ghh;f;fg;gbDk; gpuk;kKdp $w;Wg;gb 
fuj;jpy; ehb ghh;g;gJ rpwe;jJ. 
 ‘Ngh;e;jplNt rfyUf;Fq; fuj;jpdhb 
  Ngrpdhh; gpuk;kKdp NgrpdhNu” 
khj;jpiuasT (Rhythm of pulse) 
  ‘nka;asT thjnkhd;W 
   Nky;gpj;j Nkhuiuahk; 
  Iaq;fhnyd;Nw mwp” 
     -fz;Zrhkpak; 
1. ehb (Pulse) 
 thjk;> gpj;jk;> fgk; %d;Wk; 1: ½ : ¼ vd;w khj;jpiuastpy; Njfk; 
ed;dpiyapypUg;gijr; rpj;jh;fs; fzf;fpl;bUf;fpwhh;fs;. 
 Nehapy; Ma;thsuhy; Kad;w mstpy; ghpNrhjpj;J mwpag;gl;l ehb 
 thjgpj;j ehb 
 thjfg ehb 
2. ];ghprk; (Tactile) 
 fug;ghd; Neha; ghjpf;fg;gl;l ,lj;jpy; FU> nfhg;Gsk;> Gz;> jbg;G> 
nrjpy; Nghd;w Rug;G> typ fhzg;gl;lJ. 
3. eh (Tongue) 
 fug;ghdhy; ghjpf;fg;gl;l xU rpy Nehahsh;f;F eh cyh;e;J 
fhzg;gl;lJ. 
4. epwk; (colour) 
 fug;ghdhy; ghjpf;fg;gl;l rpy gFjpfspy; Njhy; rpte;Jk;> fWj;Jk; 
fhzg;gl;lJ. 
5. nkhop (Speech) 
 cuj;j xyp> rk xyp> jho;e;j xyp> rhpj;jy;> gpjw;wy;> Fswy; 
Mfpatw;iw ftdpj;jwpjy; Ntz;Lk;. fug;ghd; Nehapdh;f;F nkhopapy; vt;tpj 
mrhjhuz khWjy;fSk; fhzg;gltpy;iy. 
6. tpop (Eye) 
 rpyUf;F tNahjpfj;jpd; fhuzkhf fz;Giu (cataract) fhzg;gl;lJ. 
,d;Dk; rpyUf;F fz;nzhpr;ry; ,Ue;jJ. 
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7. kyk; (Stools) 
 fug;ghd; gpzpahsh; rpyUf;F kyr;rpf;fy; fhzg;gl;lJ. 
8. %j;jpuk; (Urine) 
m) ePh;f;Fwp 
 ‘te;j ePh;f;fhpvil kzk; EiuvQ;rnyd; 
  iwe;jpaYsit aiwFJ KiwNa” 
 epwk;> kzk;> Eiu> vil> vQ;ry; vd;Dk; Ie;J ,ay;fspy; ghpNrhjpj;J 
mwpa Ntz;Lk;. 
M) nea;f;Fwp: 
  ‘mUe;Jkh epujKk; mtpNuh jkjha; 
   m/fy; myh;jy; mfhyT+z; jtph;j;jow; 
  Fw;ws tUe;jp cwq;fp itfiw 
   Mbf;fyrj; jhtpNafhJ nga; 
  njhUK$h;j;jf; fiyf;Fl;gL ePhpd; 
   epwf;Fwp nea;f;Fwp epUkpj;jy; flNd” 
        -Njiuah; 
 Nkw;$wpa tpjp nghUe;jpa rpWePhpy; xU Jsp vz;nzia rpjwhky; 
tpl;L mJ guTfpd;w tpjj;ij njhpe;J nfhs;s Ntz;Lk;. 
thjePh;: 
 ‘muntd ePz;bd‡Nj thjk;” 
  vz;nza;j;Jsp ghk;igg; Nghy; gutpdhy; mJ thjePh;. 
gpj;jePh;: 
 ‘Mop Nghw;gutpd; m‡Nj gpj;jk;” 
 vz;nza;j;Jsp Nkhjpuk; Nghy; ,iltpl;Lg; gutpdhy; me;ePh; gpj;jePh;. 
fgePh;: 
 ‘Kj;njhj;J epw;fpd; nkhoptnjd; fgNk” 
 vz;nza;j;Jsp tpl;lJ tpl;llthNw rpwpJk; guthky; Kj;Jg;Nghy; 
epw;Fkhdhy; me;ePh; Ia ePh;. 
 thj fug;ghd; Nehapy; fgePh; fhzg;gLfpwJ. 
   fgePh;  - 60% 
   gpj;jePh; - 30% 
   thjePh;  - 10% 
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Kf;Fw;w ePh;: 
 ‘mOe;J nea;f;Fwp mJTKk;ky;yj;jpy;” 
  ePhpy; vz;nza;Jsp mOe;jpdhy; mJ Kf;Fw;w ePh;. 
  jdpj;jdpAz;lhd nea;f;Fwpfnsy;yhk; xd;wplj;jpNyNa 
fhzg;gLtJ Kf;Fw;w ePh;. 
gpw ghpNrhjid Kiwfs;: (Other Diagnostic Parameters) 
1. caph;j;jhJf;fs; 
2. VO clw;fl;Lfs; 
3. QhNde;jpupaq;fs; 
4. fd;Nke;jphpaq;fs; 
5. gUtfhyq;fs; 
6. Itif jpiz 
7. cly; td;ik 
1. caph;j;jhJf;fs;: 
thjk;: 
 thjk; vd;gJ thA> thA vd;gJ capiuf; Fwpg;gJ> jphpNjh\q;fspy; 
thjNk Kjd;ikahdJ. 
thOkplk;: 
 mghdd;> kyk;> ,lfiy> ce;jpapd; fPo; %yk;> fhkf;nfhb> ,Lg;G> 
vYk;G> Njhy;> euk;Gf; $l;lk;> fPy;fs;> kaph;f;fhy;fs;> Cd;. 
thjj;jpd; gphpTfs; (gj;J) 
1. gpuhzd; 
2. mghdd; 
3. tpahdd; 
4. cjhdd; 
5. rkhdd; 
6. ehfd; 
7. $h;kd; 
8. fpUfud; 
9. Njtjj;jd; 
10. jdQ;nrad; 
fug;ghd; Nehapdh; rpyUf;F mghdd;> tpahdd;> rkhdd;> $h;kd; 
Njtjj;jd; ghjpg;gile;Js;sJ. 
mghdd; - kyf;fl;L> ePh; vhpr;ry;. 
tpahdd; - clypy; FUf;fs;> Gz;fs; Njhd;wy; 
rkhdd; - kw;w thAf;fshy; ghjpg;G 
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$h;kd; - ghh;it ghjpg;G 
Njtjj;jd; - Cwy; kpFjpahy; J}f;fkpd;ik 
gpj;jk;: 
thOkplk; 
 gpq;fiy> gpuhzthA> ePh;g;ig> %yhf;fpdp> ,Ujak;> jiy> 
nfhg;G+o;> ,iug;ig> tpah;it> ehtpY}Wfpd;w ePh;> nre;ePh;> rhuk;> 
fz;> Njhy; ,itfs; thOkplq;fshFk;. 
gpj;jk; Itifg;gLk; mitahtd.. 
1. mdw;gpj;jk; (Mf;fdy;) 
2. ,uQ;rfk; (tz;z vhp) 
3. rhjfk; (Mw;wyq;fp) 
4. gpuhrfk; (xs;nshspj; jP) 
 fug;ghd; Nehapdh; midtUf;Fk; gpuhrfk; ghjpf;fg;gl;Ls;sJ. 
5. MNyhrfk; (Nehf;foy;) 
 fug;ghd; Nehapdh; rpyUf;F Nehapd; jd;ikf;Nfw;g mdw;gpj;jk;> 
,uQ;rfk;> gpuhrfk;> MNyhrfk; ghjpg;gile;Js;sJ. 
 mdw;gpj;jk;  - czT nrhpahik (Indigestion of  food) 
 ,uQ;rfk;  - cs;ehf;F> fz;fs; ntSj;jpUj;jy; 
 gpuhrfk;  - Njhypd; epwk; fUj;jy;> Gz; cz;lhjy; 
 MNyhrfk;  - ghh;it ghjpg;G 
 Iak; 
thOkplk;: 
 rkhdthA> ROKid. ntz;zPh;> jiy> Mf;fpid. ehf;F> cz;zhf;F> 
nfhOg;G> kQ;ir> FUjp> %f;F> khh;G> euk;G> vYk;G> %is> ngUq;Fly;> fz;> 
fPy;fs;. ,itfshFk;. 
Iak; Ie;J tifg;gLk; mitahtd: 
1. mtyk;gfk; (mspiaak;) 
2. fpNyjfk; (ePh;g;gpiaak;) 
3. Nghjfk; (Ritfhizak;) 
4. jw;gfk; (epiwitak;) 
5. re;jpfk; (xd;wpiaak;) 
fug;ghd; Nehapdh; rpyUf;F mtyk;gfk;> fpNyjfk;> re;jpfk; 
ghjpg;gile;Js;sJ. 
  mtyk;gfk;   - gw;Wf; Nfhlha; ,Uf;fpwJ 
  fpNyjfk;  - grpapd;ik> nrhpahik 
  Kf;Fw;wj;jpw;Fk; mWRitf;Fk; cs;s njhlh;G: 
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thpir 
vz;. 
Fw;wk; kpFjpg;gLj;Jk; 
Ritfs; 
rkdk; 
nra;Ak; Ritfs; 
1 thjk; 
(thA  + Mfhak;) 
fhh;g;G 
ifg;G 
Jth;g;G 
,dpg;G 
Gspg;G 
cg;G 
2 gpj;jk; 
(jP) 
Gspg;G 
fhh;g;G 
cg;G 
Jth;g;G 
,dpg;G 
ifg;G 
3 fgk; 
(kz; + ePh;) 
,dpg;G 
Gspg;G 
cg;G 
fhh;g;G 
Jth;g;G 
ifg;G 
 
Rit> gQ;rG+jk; Kf;Fw;wk; ,itfSf;fpilNa cs;s njhlh;G: 
thpir 
vz; 
Rit gQ;rG+jk; Kf;Fw;wk; 
1 ,dpg;G gpUjptp + mg;G fgk; >  
thjk; (-)  
gpj;jk; (-)  
2 Gspg;G gpUjptp + NjA fgk;  
gpj;jk;  
thjk; (-)  
3 cg;G mg;G + NjA fgk;  
gpj;jk;  
thjk; (-)  
4 ifg;G thA + Mfhak; thjk;  
fgk;  
gpj;jk; (-)  
5 fhh;g;G thA + NjA thjk;  
gpj;jk;  
fgk; (-)  
6 Jth;g;G gpUjptp + thA thjk;  
fgk;  
gpj;jk; (-)  
 
-tsh;r;rp (-) rkg;gLjy; 
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2. VO clw;fl;Lfs;: 
  ‘,urk; cjpuk; ,iwr;rp Njhy; Nkij 
   kUtpa tj;jp thOk; nkhU kr;ir 
  gutpa Rf;fpyk; ghohk; cghjp 
   cUgk yhDly; xd;nwdyhNk 
       - jpU%yh; jpUke;jpuk; 
1. rhuk; (chyle) 
2. nre;ePh; (Blood) 
3. Cd; (Muscle) 
4. nfhOg;G (Fat) 
5. vYk;G (Bone) 
6. %is (Bone Marrow) 
7. ntz;zPh; (Sperm) 
fug;ghd; Nehapy; rhuk;> nre;ePh;> Cd;> nfhOg;G ghjpf;fg;gLfpwJ. 
 rhuk;  - cliyAk; kdijAk; Fd;wr; nra;fpwJ  
    (Mental stress) 
 nre;ePh;  - Njhypd; epwk; khw;wk; miljy; 
    (Discoloration of the skin) 
 Cd;  - Njhypy; nfhg;Gsk; fl;b cz;lhjy; 
    (Formation of vesicles) 
 nfhOg;G - nea;g;G girapd;wp cly; twz;L fhzy; 
    (Dryness of the skin) 
 
VO clw;fl;Lfs;> Kf;Fw;wk;> gQ;rG+jk; ,tw;wpw;fpilNa cs;s njhlh;G. 
t.vz;. Fw;wk; jhJ gQ;rG+jk; 
1 thjk; vd;G ePh; + kz; 
2 gpj;jk; 
rhuk;> nre;ePh;> 
Cd; 
ePh; + Mfhak;> 
kz; + ePh;> ePh; + 
jP. 
3 fgk; 
nfhOg;G> %is> 
Rf;fpyk; / 
RNuhzpjk; 
kz; + kz;> ePh; 
+ thA 
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3. QhNde;jphpak;: 
 fug;ghd; Nehapdh;f;F nka;. fz; ghjpf;fg;gl;Ls;sJ 
 nka; - Njhypy; rpW nfhg;Gsq;fs; fhzy;> ePh; frpT Njhd;wy; 
 fz; - ghh;it ghjpg;G 
4. fd; Nke;jphpaq;fs; 
 fug;ghd; Nehapy; if> fhy;> vUtha; ghjpf;fg;gl;Ls;sJ. 
if -  ePl;b klf;f rpukk; 
 (Njhypy; Vw;gLk; FUf;fs;> nfhg;Gsq;fs;) 
fhy; - ePl;b klf;f rpukk; 
 (Njhypy; Vw;gLk; FUf;fs;> nfhg;Gsq;fs;) 
 vUtha; - kyf;fl;L 
5. gUt fhyq;fs; 
fhy xOf;fk;: 
 gd;dpuz;L jpq;fs; nfhz;l Xh; Mz;il MW gphpTfshf gphpf;f ,uz;L 
jpq;fisf; nfhz;l xt;nthU gphpTk; fhyk; vdg;gLk;. mf;fhyq;fspy; epfOk; 
khWjYf;Fj; jf;fthW Neha; tuhkypUf;f rpy xOf;f tpjpfis rpj;jh;fs; 
$wpAs;sdh;. mJNt> ‘fhy xOf;fk;” vdg;gLk;. 
t.vz;. fhyk; Fw;wk; Rit 
1 
fhh;fhyk; 
Mtzp> Gul;lhrp> 
(Mf];l; 16 - mf;Nlhgh; 15) 
thjk; 
gpj;jk; 
,dpg;G 
Gspg;G 
cg;G 
2 
$jph; fhyk; 
Ig;grp> fhh;j;jpif 
(mf;Nlhgh; 16 - brk;gh; 15) 
thjk; 
gpj;jk; 
,dpg;G 
ifg;G 
Jth;g;G 
3 
Kd;gdp fhyk; 
khh;fop> ij 
(brk;gh; 16 - gpg;uthp 15) 
gpj;jk; 
,dpg;G 
Gspg;G 
cg;G 
4 
gpd;gdp fhyk; 
khrp> gq;Fdp 
(gpg;uthp 16 - Vg;uy; 15) 
fgk; 
,dpg;G 
Gspg;G 
Jth;g;G 
5 
,sNtdpy; fhyk; 
rpj;jpiu> itfhrp 
(Vg;uy; 16 - [{d; 15) 
fgk; 
ifg;G 
fhh;g;G 
Jth;g;G 
6 
KJNtdpy; fhyk; 
Mdp> Mb 
([{d; 16 - Mf];l; 15) 
thjk; 
fgk; 
,dpg;G 
 
6. Itif jpiz: 
 FwpQ;rp (Hill area)  - kiyAk; kiyrhh;e;j ,lKk; 
 Ky;iy (Forest area) - fhLk; fhL rhh;e;j ,lKk; 
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 kUjk; (Fertile land)  - taYk; tay; rhh;e;j ,lKk; 
 nea;jy; (Coastal area) - flYk; fly; rhh;e;j ,lKk; 
 ghiy (Desert land)  - kzYk;> kzy; rhh;e;j ,lKk; 
 
7. cly; td;ik: 
 cly; td;ikahdJ. ,aw;if td;ik> nraw;if> td;ik> fhytd;ik 
vd %d;W tifg;gLk;. 
1. ,aw;if td;ik: 
 ,J rj;Jt> uN[h> jNkh Fzq;fspdpd;Wk; ,aw;ifahfNt cz;lhtJ. 
2. nraw;if td;ik: 
 cliy mjd; Fzj; jd;ikf;F chpa czthjp nray;fshYk;> 
clw;fl;Lfspd; td;ik nflhtz;zk; epiy epWj;jf;$ba kUe;JfshYk; 
fhj;Jf; nfhs;tjhy; cz;lhtJ. 
3. fhy td;ik: 
 ,J tajhYk;> ,sNtdpy; Kjypa ngUk;nghOjhYk; cz;lhtJ. 
 cly; td;ik ghjpf;fg;gLk; NghJ fug;ghd; Neha; cz;lhfpwJ. 
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Kf;Fw;w NtWghLfs; 
 ‘kpfpDq; FiwapDk; Neha; nra;Ak; E}Nyhh; 
  tsp Kjyh vz;zpa %d;W” 
        -jpUf;Fws; 
 #f;Fk rhPuq;fshfpa rg;j jhJf;fSk; tsp> moy;. Iakhfpa 
Kf;Fw;wq;fSk; jj;jk; ,aw;if jd;ikapdpd;Wk; NtWgLk; epiy Neha; 
vdg;gLk;. 
 czT Kiw> gof;f tof;fq;fs;> fhykhWghLfshy;> thjk;> gpj;jk;> 
fgk; %d;W jhJf;fSk; jd;dpiy gpwo;e;J Nehia cz;lhf;FfpwJ. 
 fug;ghd; Nehapy; jd;tpid> gpwtpidfspd; gadhfj; J}z;lg;gl;l 
Iaf;Fw;wkhdJ> tsp moy; Jiz nfhz;L Fwp Fzq;fis cz;lhf;FfpwJ. 
  ‘jhdKs;s Nrj;J ke;jhdpsfpy; ntg;G 
   rakPis ,Uky;ke; jhu fhrk; 
  <dKWQ; re;eptpl Njhlk; tpf;fy;> 
   apUj;Nuhfq; fug;ghd; tpuz Njhlk; 
  khdidaPh; #iyjpus; tpahjp tPf;fk; 
   tUQ;rj;jp Rthrk; neQ; rilg;G J}f;fk; 
  VdKWq; fhkhiy ghz;L Nrhig 
   VOfuq;fs; gyJf;fk; tplKz;lhNk” 
        - rjf ehb 
thj kpFjpAld; c\;zk; Nrh;tjhYk; cz;lhfpwJ 
  rpwg;ghd thjj;jpYl;bze;jhNd 
   Nrh;e;jpLfp yjprhu Kisr;ry; thA 
  ciug;ghd nghUknyhL mf;fpdp ke;jk; 
   cs;shFk; ePh;r;rpWg;G gpuNkf fq;fs; 
  gpwg;ghL kjfhpePh; fug;ghd; uj;jk; 
   gpuNkfk; ngUk;ghL GwePh;f;Nfhit 
  mwg;ghd thA#iy Nrj;Jk Nuhfk; 
   Mdgy gpzpfSNk te;jlUe; jhNd” 
        -rjf ehb   
 Njhy; kz; + NjA G+jq;fshy; Mf;fg;gl;lJ. 
 Gspg;G Rit kz; + NjA G+jq;fshy; MdJ> Mjyhy; Njhy; Neha; 
rhh;e;jtUf;F Gspg;G Rit ePf;fTk;. 
 fgk; jd;dpiy nfLtjhy; Njhy; Neha;fs; tUk; (guuhrNrfuk;) 
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 Njhypd; Nky; tho;tJ thjk;> Mjyhy; fgk; jd;dpiy miltjw;Fk; 
thjk; rPuiltjw;Fk; Vw;g kUe;Jfs; toq;fTk;. 
   ‘tpNurdj;jhy; thje; jhOk;” 
   ‘thjkhdJ Nkdp nflhJ” 
 vd;gjw;Nfw;g fopr;ry; kUe;Jfs; nfhLj;J thjj;ij rkepiy mila 
nra;aTk;. 
 ‘ntsis vz;nza;” - 15ml mstpy; nfhLf;Fk; NghJ kykpsf;fp 
(Laxative) Mf gad;gLk;. 
ifg;G Rit: 
 thjj;ij tpUj;jp nra;Ak; 
 fggpj;jq;fis rkdg;gLj;Jk; 
 Ff;fpyhjp #uzk; ifg;G fhh;g;G Rit ,Ug;gjhy; fg gpj;jq;fis 
rkg;gLj;jp fug;ghd; Nehia Fzg;gLj;JfpwJ. 
gpzp ePf;fk;: 
gpzp ,U tifg;gLk;. 
1. Kf;Fw;wq;fspd; Ntw;Wikahy; clw;gpzpnad;Wk; 
2. Kf;Fzq;fspd; Ntw;Wikahy; csg;gpzpnad;Wk; ,Utifg;gLk;. 
  kUj;Jtk; vd;gJ gpzpia ePf;FtJld; gpzp tuhky; fhf;fTk; 
top tFf;f Ntz;Lk;. mjhtJ  
  fhg;G - Prevention 
  ePf;fk; - Treatment 
  epiwT - Restoration 
fhg;G: 
 Nehapdpd;W clypidf; fhf;f rpj;jh;fs; $wpa ehs; xOf;fk;> fhy 
xOf;fk;> gpzpaZfh tpjpfis filg;gpbf;f mwpTWj;j Ntz;Lk;. 
 Nfhgk;> Jf;fk;> kd mOj;jk; ,tw;wpypUe;J tpLgl %r;Rg; gapw;rp> 
Mrdq;fis nra;a mwpTWj;j Ntz;Lk;. 
 thj> gpj;j> fg NjfpfSf;Fj; jf;fthW czT tiffis rhg;gpl 
mwpTWj;j Ntz;Lk;. 
ePf;fk; (Treatment) 
 fd;kePf;fk; 
 tpNurdk; 
 cs;kUe;J 
 ntspkUe;J 
 gj;jpak; kw;Wk; czT Kiwfs; 
 gpuhzhahkk; kw;Wk; Mrdq;fs; 
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1. fd;k ePf;fk;: 
  ‘cz;iknad;w fug;gndhL tz;Lfb Fl;;l 
   KyfpYs;Nshh;f; fpJte;j Tz;ikNfS 
  thwhd ePh;tplk;Nghy; te;j Njhl 
   khw;wnthU epth;j;jp nrhy;Ntd; kUtpf;NfS 
  $whd fzgjpf;F new;nghhp atYq; 
   nfhl;ilnad;w Njq;fha;jhd; gj;JE}W 
  tPwhd apsePUk; gj;J E}W 
   nts;spnad;w fpoikapNy goe;jhd;E}W 
  rhwhd tpsePhpy; Kg;goKk; gpire;J 
   rz;Kfdhh; jikaDf;fgp NlfQ; nra;Na” 
  ‘nra;jgpd;G Njq;fhianaLj;jr; #iw 
   rpjwNt cilj;jpLth ahap ue;jhd; 
  nfha;jpkyh; rpuRjdpw; nghjpAq; nfhl;bf; 
   $l;bnay;yhk; thjpNa nfhs;is nad;W 
  igay;fSf; fPe;jhf;fhw; ghte; jPUk; 
   gjpthfj; J}gKld; jPgq; fhl;L 
  va;jnjhU fd;kj;ij epth;j;jp nra;jh 
   ypLkUe;J nrhy;Yfpw dpjkha;f; NfNs” 
       -mfj;jpah; fd;k fhz;lk; 
 Mya topghL kw;Wk; <if nra;jy; Nghd;wit kdcisr;riy (Stress) 
Fiwf;fpd;wJ. 
 Njhl;lq;fsikj;jy; 
 nghJf; fpzWfs; ntl;Ljy; (jw;fhyk; fpzWfspy; ePh; Cw;Wfs; 
twz;L tpl;lgbahy;> FbePUf;fhd gpw topfisg; gad;gLj;jyhk;. 
c.k;.jz;zPh; ge;jy; mikj;jy;) 
 nghJkf;fspd; cgNahfj;jpw;nfd rhiyfs; mikj;jy;. 
 kuq;fis tsh;j;jy;. 
2. tpNurdk;: 
 jd;dpiy gpwo;e;j Fw;wq;fisj; jd;dpiyg;gLj;j fopr;ry; kUe;J 
toq;f Ntz;Lk;. 
 nts;is vz;nza; 15ml fhiyapy; ghypy; nfhLf;f Ntz;Lk;. 
 
3. cs; kUe;J: 
 Ff;fpyhjp #uzk; 1 fpuhk; ,UNtis nte;ePhpy; (Nehapd; jd;ikf;Fj; 
jf;fthW) 
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4. ntsp kUe;J: 
 fug;ghDf;F vz;nza; 
5. gj;jpak; kw;Wk; czT Kiw: 
  ‘gj;jpaij NehiaaD ghdj;ij yq;fzj;ijg; 
   gj;jpaj;ij Kd;kUtd; gz;zypw;nfhs; - gj;jpaj;ij 
  Vfkh ahh;j;jhY Nkwhr; nrtptopNghNdha; 
   Vfkh ahh;j;jhY nka;” 
      -Njud; akf ntz;gh 
fug;ghd; Nehapid cz;lhf;ff;$ba kw;Wk; mjpfg;gLj;jf;$ba czT 
tiffis ePf;f Ntz;Lk;. mitahtd. 
Nrhsk; - Sorghum vulgare 
  ‘Nrhsnkdg; Nghh; gilj;j NrhWfspdhYk; clypy; 
   kPshr; nrhwprpuq;F tph;j;jpahFk; ehSq; 
  fug;ghDk; cz;lhk; fdkUe;Jk; ghohk; 
   gug;gida fz;khNj ghh;” 
nfhs; - Dolichos biflours 
  ‘Fly;thjq; Fd;kKz;lhq; nfhs;kUe;Njh ehrk; 
   mlNyW gpj;jkpf MFq; - fLfLj;j 
  thj ePNuw;wnkhL kd;DFsph; fha;r;rYk;NghQ 
   rhjp eWq; nfhs;Sf;Fj; jhd;” 
ghfy; - Memoridica charantia 
  kUe;Jfspd; ew;Fzj;ij khw;Wk; m‡jd;Nwh 
   jpUe;jtyp thjj;ijr; Nrh;f;Fk; - nghUe;Jgpj;jq; 
  $l;Lkjp gj;jpaijf; nfhz;bUf;Fk; td;fug;ghd; 
   fhl;Lf; nfhk;Gg; ghfw; fha;” 
  ‘gpj;jnkhL thjg; ngUf;if kpf cz;lhf;Fe; 
   je;J fug;ghidj; jUtpf;Fk; - gw;wp uj 
  jhu ghlhze; jik Kwpf;Fe;j jg;ghJ 
   fhuty;ypahk; ghfw;fha;” 
 
rpy kPd; tiffisAk; ePf;f Ntz;Lk;. 
   ‘kapwp Fwit tuhy; Njsp 
  kw;Wk; Fwit eha;f; nfspW 
   mapiu rd;id gj;jpakhk; 
  Mfh kPd;fs; ,dpfNfSk; 
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   caUk; this ,why; $dp 
  Xq;F nfspW tpyhq;F nfz;il 
   faNyhbitfs; Mfhthq; 
  fhuhh; FoNy fz;LiuNa” 
nfha;ah - Psidium guajava 
  ‘jphpNjh\k; nrd;dpj; jpUg;g kNuhrp 
   ngUke;jk; the;jp nghUky; - fug;ghDk; 
  nka;aha; guT kyk; nkj;jtUk; NghfKz;lhq; 
   nfha;ah goj;jpdhw; $W” 
Kl;il - Gallus domesticus 
  ‘thjgpj;jQ; Nrh;g;gpf;Fk; td;Nwhlk; Gz;zhf;Fe; 
   jhJit nkj;j jiog;gpf;F - NkhJ 
  fgj;ij alf;Fq; fug;ghDz;lhf;F 
   kpgj;ijAWq; NfhopKl;il nad;” 
cg;G - Sodium chloride 
  ‘nrhl;il eiu jpiu Jl;;lePh; gk;G Gz; 
   kl;l;w ehtwl;rp thjuj;jk; - Fl;lKz;lhk; 
  Njftd;ik NjAk; jpUNtjpdk; mjpf 
   khfTg;ig Az;lhff; fwp. 
fj;jhp - Solanum melogena 
  ‘gz;L khz;l fpue;jpiag; ghjpf;Fk; 
   cz;l iff;Fe; jpdit Az;lhf;fptpLk; 
  ez;L fl;Lq; Fuq;nfd ehSkhq; 
   fz;L tpl;lJ fj;jhpf; fhaNj” 
khk;gok; - Magnifera indica 
   jpd;whw; epdntLf;Fe; jPgdk; Nghk; neQ;nrhpthk; 
  md;Nw tpopNeha; mlUq;fhz; - Ed;wpkpf 
   thjfug;ghDk; td; fpue;jpAk; ngUFQ; 
  #jf; fdpapd; Rfk;. 
Gsp - Tamarindus Indica 
  ‘Gj;jpAk; ke;jkhFk; nghUkpNa clY%Jk; 
   gj;jpak; jtWk; re;jp ghjkhk; Ruq;fs; tPWQ; 
  rh;j;jpAk; gpj;Je; jPUk; jDntDk; thj NkWk; 
   kj;jpae;j jhJG\;b tUe;jpiu eiu Gspf;Nf” 
      -gjhh;j;j Fz rpe;jhkzp 
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 ,tw;Wld; fk;G> tuF. fhuhprp> thiof;fha;> jbaq;fha; ,tw;iwAk; 
ePf;f Ntz;Lk;. 
 vspjpy; rPuzpf;Fk; czT tiffis vLj;Jf; nfhs;sy; eyk;. 
 kuf;fwp czT> ghy; kw;Wk; ghy; nghUs;fs;> rj;Js;s czTfs; 
cl;nfhs;syhk;. 
 krhyhg; nghUl;fs; (spicy foods) kzg; nghUl;fs;> Nghijg; nghUl;fs;> 
fhug; nghUl;fs; ePf;f Ntz;Lk;. 
 kPd;> Kl;il> fUthL> Nfhopf;fwp> Nghd;wtw;iwj; jtph;f;fTk;  
 rTf;fhuk; $lhJ (Don‟t use soaps) 
 Fspg;gjw;F eYq;Fkh gad;gLj;jTk; 
 ghrpg;gapW> fliykhT Nghd;wtw;iwAk; Fspg;gjw;Fg; gad;gLj;jyhk;. 
epiwT (Restroration) 
 Neha;f;Fg; gpd;dh; clypid gioa epiyf;F nfhzh;jy; Kw;$wpa 
czT gj;jpa KiwfisAk; Mrdk; gpuhzhahk KiwfisAk; 
njhlh;e;J filgpbf;f mwpTWj;j Ntz;Lk;. 
 Mrdk; nra;tjd; %yk; Neha; vjph;g;G rf;jp mjpfhpf;Fk;> kd 
cisr;ry; FiwAk;> mwpT jpwd; $Lk;. 
mDghdk;: 
 rpj;j kUj;Jtj;jpy; mDghdk; Kf;fpaj;Jtk; tha;e;jJ. jf;f 
mDghdj;jpy; nfhLf;Fk; NghJ jhd; kUe;J KOg;gyidAk; nfhLf;Fk;. 
  ‘mDghdj;jhNy atpo;jk; gypf;Fk; 
   ,dpjhd Rf;F fd;dy; ,Q;rp - gpD Kjfhy; 
  NfhNkak; ghy; Kiyg;ghy; Nfhnea; - Njd; ntw;wpiyePh; 
   Mkpij ahuha;e;J nra;ayhk;” 
       -Njud; ntz;gh 
Ff;fpyhjp #uzj;ij nte;ePhpy; mDghdpj;Jf; nfhLf;f fug;ghd; Neha; jPUk;. 
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STEAM BATH 
Introduction 
 A room that is filled with hot steam for the purpose of cleansing and Steam 
bath refreshing the body and for relaxation. It is a restorative concept of steam, to 
revive our overall health and enhance appearance. 
Types 
 The difference between a sauna and a steam room can be summed up simply -- 
dry vs. wet. 
  Sauna provides dry heat, while steam room generates moist heat. Both can 
open up your pores, loosen up your muscles and help you relax 
Prepatory procedure 
 Take a shower before you use the steam bath to remove dirt and oils. Remove 
any metal jewellery. Metal conducts heat very efficiently and can heat up in the steam 
room to the point where it could be uncomfortable or even burn you. And 
recommends you remove the contact lenses before enter the steam room 
Dress code 
 For mens is shorts and for womens is towel and preferred material is cotton 
Rest 
 Patient can lie down, plan to relax. Ask to close the patient eyes if you like, 
breathe deeply and focus on letting the heat soak in and relax you. Remain there as 
long as you are comfortable, which can be as little as 5 minutes or as long as 20 
minutes. 
 Recover 
 Take a cool shower, then rest and allow your body to return to normal 
temperature. Drink some water and enjoy this break from a busy day. 
Merits and demerits 
1-Vasodilatation -Benefits 
 Both steam rooms and dry saunas cause the blood vessels in the skin to dilate, 
in part accounting for the warm glow appearance afterwards. The blood flow out of 
the heart increases by 2 or more times after a 10 to 15 minute steam room or sauna 
exposure. 
 
Risks :  
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 However, the blood flow to the internal organs actually decreases, because so 
much blood is being directed to the skin instead. 
 This can be a problem for folks with coronary heart disease. 
 
2.Analgesia –Benefits: 
Heat has long been recognized as beneficial for folks with fibromyalgia, arthritis and 
other painful conditions. 
 
Risks: 
 If heat exposure is extreme, excessively prolonged, or if the individual has 
underlying irritation of the skin, heat can cause the equivalent of a sunburn, or 
thermal burn. 
 In addition, steam exposure may be a concern if you have had recent 
surgery(particularly if sutures are still in place) or if you have an open or 
infected wound 
3-Antispasmodic– 
Benefits: 
 Heat tends to cause relaxation of the musclesand many individuals note 
improved recovery ofmuscle soreness and decreased problems with delayed muscle 
soreness when they use a sauna or steam room after exercise. 
4-Diaphoresis (sweating)–Benefits: 
 The average person will sweat about a pint during a 15 minute session in a 
sauna, depending on the person‟s acclimatization to heat exposure 
 This has theoretical benefits for cleansing skin pores and some people believe 
sweating helps clear toxins from the body. This is not well proven and in many in 
stances, is simply not true. In general, people with documented toxicant accumulation 
in their bodies benefit from specific medical treatment directed at the specific 
toxicants, rather than sweating. In addition, many of the toxicants of concern these 
days, for example: pesticides and many metals, asbestos, are not cleared very well 
through the sweat. 
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Risks: 
 The effect of both wet and dry heat to increase fluid loss from the body can 
also be a problem, particularly in folks who are already somewhat dehydrated 
(e.g. after heavy exercise within adequate fluid replacement or in response to 
the diuretic effects of caffeine, beverage alcohol, and medications (diuretics). 
Dehydration can be a problem in people who have blood vessel blockages to 
the brain and the heart. Some individuals experience an increase in their 
migraine headaches in response to dehydration. 
 There are a number of other medications that can affect the body‟s normal 
response to heat either by inhibiting sweating or by otherwise interfering with 
the normal physiology, for example, some medications used for psychiatric 
conditions like schizophrenia. Use of stimulant medications for conditions like 
ADD or excessive sleeping also increases the health risks from heat exposure 
 
5-Sedative-Benefits: 
 Heat exposure through a dry sauna or steam room causes a sense of relaxation 
for many people, with both muscle relaxation and a reduction in the sense of stress 
and  anxiety. Many people find use of steam rooms and saunas  
improves the quality of their sleep 
 
6-Expectorant: 
Benefits: Steamheat (not dryheat) can have therapeutic benefits for thinning 
mucous lining it easier for some individuals to cough up phlegm.Itcan also free up 
sinus passage ways and Eustachian tubes in individuals with sinus and Eustachian 
tube problems. 
 
Risks: 
 This same effect can trigger increased problems with wheezing and chest 
tightness in some asthmatics and other individuals lung disease, particularly 
 If they have noted problems when taking a steamy shower previously. 
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7-Calorie Burn Benefits:  
 Although exposure to heat increases energy consumption and there by 
increases calorie burn, for example, up to 300 to 400 Kcal during 20 to 30 minute 
sauna bath, us helping to promote weight loss,  
 
Risks: 
 Individuals who have been cautioned to restrict exercise intensity by health 
care providers should be aware that the effects of heat are similar to those of 
exercise for increasing heart rate. 
 Increasing energy consumption through increased work of the heart can be a 
concern for people with coronary heart disease, congestive heart failure, 
valvular heart disease or heart rhythm problems  
 
Scientific evaluation: 
Although sauna bathing causes various acute, transient cardiovascular and 
hormonal changes, it is well tolerated by most healthy adults and children.. Some 
studies have suggested that long-term sauna bathing may help lower blood pressure in 
patients with hypertension and improve the left ventricular ejection fraction in 
patients with chronic congestive heart failure, but additional data are needed to 
confirm these findings. Sauna bathing may also alleviate pain and improve joint 
mobility in patients with rheumatic disease. Although sauna bathing does not cause 
drying of the skin-and may even benefit patients with psoriasis-sweating may increase 
itching in patients with atopic dermatitis. Contraindications to sauna bathing include 
unstable angina pectoris, recent myocardial infarction, and severe aortic stenosis. 
Sauna bathing is safe, however, for most people with coronary heart disease with 
stable angina pectoris or old myocardial infarction. Very few acute myocardial 
infarctions and sudden deaths occur in saunas, but alcohol consumption during sauna 
bathing increases the risk of hypotension, arrhythmia, and sudden death, and should 
be avoided. 
 
Demerits of steam room  
Infection 
 Bacteria and fungi prefer damp, warm environments with little light. This 
makes steam rooms perfect breeding grounds for infections to spread. One of the most 
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common is athlete's foot, or tinea pedis, which can occur when your bare feet are 
exposed the floor of a steam room. Athlete's foot causes stinging, itching, and burning 
between toes and other areas on your foot. Another common fungal infection is jock 
itch, or tinea cruris, that affects the upper thigh, genital and buttocks. If someone who 
has jock itch was sitting on a bench in a steam room, it increases the likelihood the 
next person who sits there may become infected as well. Always wear shoes in a 
steam room, and if you sit on a bench, place a clean towel beneath you. 
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MODERN ASPECTS 
Skin anatomy 
 The skin is the largest organ in the body. The skin and its appendages(hair, 
nails, sweat and oil glands) make up the integumentary system. Among its many 
functions the skin is an incredible organ always protecting the body from external 
agents. 
 Our skin is built up of two main layers. Within these two layers there are a 
range of different skin cells, sub layers, nerves, blood vessels, sweat and oil glands, 
hair follicles, collagen and elastin fibres. The structure of the 3 layers of skin – the 
epidermis, dermis and subcutaneous tissue. 
Structure of the skin 
 Epidermis- outermost layer 
 Basement membrane – middle layer 
 Dermis- the deeper connective tissue layer 
 Epidermis 
 The epidermis is formed of non- vascular stratified epithelium. It is the 
outermost layer and predominantly composed of keratinocytes. 
Keratinocytes 
 Keratins – horn like 
 Cytes – cells 
 Keratinocytes comprises 65%of epidermal cells. It synthesis a range of 
structural proteins including keratins and loricrin. There are over 20 different types of 
keratin, classified into two broad group 1 basic type(type I) and acidic(type II). 
Genetic diseases that results in mutations of keratins, 
Three other cell types make up most of the remaining 5% of epithelial cells. 
Langerhan cells 
 Langerhans cells are dentritic, bone marrow derived cells that circulate 
between epidermis and the local lymph nodes, 
Melanocytes 
 Melans – black 
 Cytes – cells 
 They synthesis the pigment melanin from tyrosine. Melanin protects the skin 
from ultraviolet radiation. 
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Merkel cells 
 They are thought to play a role in signal transduction of fine touch. Merkel cell 
carcinoma has been reported recently. 
The epidermis consists of the following layers. 
Stratum germinativum 
The whole of the epidermis germinates from this stratum hencethe name stratum 
germinativum 
This is the deepest portion of the epidermis and composd of columnar cells placed 
perpendicular to the skin surface. 
Stratum malpighii (Prickle cell layer) 
It is superificial to the basal cell layer and is composed of several layers of polyhedral 
cells connected to each other by intercellular bridges. 
Stratum granulosum (Granulos – little grains) 
 It iscomposed of flat fusiform cells which are one to three layers thick. These cells 
contain  irregular granules of keratohyalin and lysosomal enzymes and cystine rich 
proteins.  
Near the granular cells layer lamellar granules also known as odland bodies are found. 
Odland bodies are discharged into the intercellular space belowthe cornified cell alyer 
and form an effective water proof barrier. 
Stratum lucidum (Lucid – clear) 
It is present only in the skin of the finger tips, palms and soles. 
Pale and wary – looking layer. This layer contains refractile droplets of eleidin 
Stratum corneum ( Corne- hard (or) hoof like) 
This is the most superificial layer, the outer surface which is exposed to the 
atmosphere. 
It consists of many layers of non- nucleated, flattered, cornified cells. 
This layer is thickest on palms and soles. 
But thinnest on the outer aspect of the lips, on the glans penis and the eyes. 
Epidermal appendages 
Sweat glands  
a. Eccrine glands 
b. Apocrine glands 
2. Sebaceous glands 
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3. Hair 
4. The nails 
1. Sweat glands 
a. Eccrine glands(Eccrine – secreting outwards) 
      They are the ordinary, small – sized (0.3-0.4mm) sweat glands which are 
distributed all over the skin expect on the beds of nails, margins of lips and the glans 
penis. 
Over 3 million sweat units are present at birth. The sweat produced by this glands 
about 600ml per day. 
The main function of these glands is regulation of temperature. 
b. Apocrine glands 
They occur in the axillae, areola and nipples of brests, umbilicus around the anus and 
the genitalia. 
Their glandular portion is very large and mayb measure 3 mm to 5mm in diameter. 
Their secretion is odoriferous with a secondary sexual significance. The number of 
sweat glands varies. They are least numerous in the neck and back 
The palm has about 370 glands/ square centimetre. 
The back of the hand about 200, for forehead 175, abdomen and forearm 155 and leg 
60-80. 
The average quantity of sweat secreted in 24 hours varies from 700-900gm. 
2. Sebaceous gland (Sebace – greasy) 
Sebaceous glands usually arises from hair follicles with their ducts discharging 
sebum into the upper part of the follicle. 
Sebum excretion is under control. 
Androgens and progesterone increase sebum excretion whereas oestrogens have an 
inhibitory effect. 
3. Hair 
Hair is found on almost every part of the body surface excepton the palms and soles, 
the inner surface of the labia, prepuce and glans penis. 
Hair growth and development, plate – like horny structures, covering the dorsal 
surfaces of the distal phalanges of the fingers and toes. 
Nails are tightly packed, hard keratinized epidermal cells. 
Basement membrane 
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The basement membrane acts as an anchor for the epidermis but allows movement of 
cells and nutrients between the dermis and epidermis. 
 
Structural components 
 Epidermal cell membrane is attached to the basement membrane via 
hemidesmosomes. 
 Lamina lucida is composed predominantly of laminin. 
 Anchoring filaments extended through the lamina lucida to attach to the 
lamina densa. 
 Bullous pemphigoid antigen cicatrical pemphigoid antigen, laminin, nidogen, 
heparin sulphate proteoglycan type IV and type VII collagens, etc are found in 
the basement membrane. 
 
Dermis 
 The dermis is vascular and supports the epidermis structurally and 
nutritionally. 
 It varies in thickness from 1mm over on the inner forearm to 4mm on the 
back. 
 The acellular part of the dermis consist predominantly of fibres, mostly 
collagens I and III but also elastin and reticulin synthesised by the major cell 
type fibroblasts. 
 Apart from fibroblasts, there is a large number of other cell types within the 
dermis including mast cells, mononuclear phagocytes, T lymphocytes, dentric 
cells, nerves and vessels. 
 
Blood supply 
The blood supply of the skin comes from a large number of arteries forming 
anastomosis in the deepest part of the corneum. From here single vessels run upwards 
and form a second network in the upper corneum. Finally terminal arterioles ascend 
into the papillae ending in capillary loops, which drain into connecting venules. The 
blood is returned to the large veins in the sub cutaneous tissue. 
 
Lymphatic drainage 
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The skin contains rich network of lymphatics, which drain into a few larger vessels in 
the hypodermis. 
 
Nerve supply 
 The nerve supply of the skin consists of motor and sensory part, the motor part 
derived from the symphathetic ganglion and sensory part derived from the dorsal root 
ganglion. The symphathetic finres innervative the blood vessels errecterous and cause 
con traction. 
 
Immunology of skin 
 The immune system consists of an intricately linked network of cells. Proteins 
and lymphoid organs which are strategically placed to ensure maximal protection 
against infection. The immune system not only protects against infection, but also 
limits excessive response that might lead to auto immune diseases. 
 Immune defences are normally categorized into innate immune response 
provides immediate protection Acquired or adaptive immune response provides long 
lasting protection. 
 
Skin act constitutive barriers 
 The tightly packed, highly keratinised cells of the skin constantly undergo 
renewal and replacement, which physically limits colonization by micro organisms. 
Microbial growth is inhibited by physiological factors such as low PH and low 
oxygen. Sebaceous glands secrete hydrophobic oils that further repel water and micro 
organisms. 
 Sweat also contains lysozyme an enzyme that destroys the structural intergrity 
of bacterial cell walls 
 Ammonia has anti bacterial properties and several anti microbial peptides such 
as defence mechanism. 
 In skin, lysozyme and anti microbial peptides can directly kill invading 
pathogens and additionaly lacto ferrin acts to starve invading bacteria of iron. 
 The constitutive barriers are highly effective, but if external defences are 
breached by a wound or pathogenic organism, the specific soluble proteins and cells 
of the innate immune system are activated. 
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Mast cells and basophils 
 Mast cells and basophils are bone marrow derived cells which play a central 
role in allergic disorders. Mast cells reside predominantly in tissues exposed to the 
external environment. Such as the skin and act while basophils are located in the 
circulation and are recruited into tissue in response to inflammation. 
 Both contain large cyto plasmic granules which enclose performed vasoactive 
substances such as histamine. Additional mediavers are synthesized do not after 
activation, including leukotrienes, prostaglandins and cystokines local release local 
blood flow and vascular permeability, stimulates smooth muscle contractions and 
increase secretion at mucousal surfaces. 
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ECZEMA 
Definition 
Dermatitis and eczema is non contagious inflammation of the skin 
characterized by erythema, scaling, oedema, vesiculation and oozing. 
Eczema has been used as a descriptive term since the sixth century. 
Eczema is a greek word( Ec-means “out”, zeo means “boil”). The whole word 
implies “boil out”. 
Eczema is a specific type of allergic cutaneous manifestation of antigen- 
antibody reaction. 
Aetiology 
Basically, two factors cause dermatitis and eczema. 
Firstly, all allergic or sensitive skin, secondly, exposure to an irritant. The 
dermatologist Darier has correctly said that, 
“There is no eczema but an eczematous patient” 
The general predisposing causes are 
Age 
Eczema sometimes occurs in infancy, at puberty and at the time of menopause. 
Genetic and familial predisposition 
There is usually a personal or family history of allergy, viz, asthma, eczema 
and hay fever. 
General debility 
By lowering resistance of the individual predisposes to eczema. 
Climate 
  Climate extremes like heat and severe cold. 
Psychological stress 
Local factors 
Xeroderma or icythosis, a greasy skin hyperhidrosis, varicose veins direct 
contact with pet and domestic animals(especially their saliva or fur) and indirect 
contact with animal dender 
Rough , scary, tight clothing, especially clothes made of wool(or) stiff fabrics. 
The frequent use of soaps and cleaning products that tend to give lack of 
normal shiny of the skin. 
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Food as allergens 
a)Animal sources 
Cow‟s milk  - casein and beta lactoglobin are known to be the major allergen. 
Egg white is the allergising factor. 
Any species of fish can responsible for allergic reactions. 
Meats of all kinds  - it has been observed that in cases of hypersensitiveness to 
the meat of a certain animal, the liver, pancreas, kidney and brain. 
b)Plant sources 
 Wheat flour – allergic reaction due to wheat gluten 
 Some workers in glue factories using soya flour as an ingredient of glue, 
develop severe allergic symptoms. 
 Peas, beans and lentils have been reported to produce allergic reactions in 
some individuals. 
 Consumption of edible mushrooms sometimes may cause allergic reactions. 
 Fats and oils have been found to produce allergic symptoms in some 
individuals. 
The vegetables which have been fiund to produce allergic reactions in some 
individuals are carrot, spinach, cabbage, onion, garlic,sweet potato, cauliflower and 
pumpkin. 
Among the fruits, strawberries, bananas, oranges, grapes and apples are the 
principal offenders. 
Occasionally allergic reactions can occur due to consumption of pears, 
cherries, plums, gooseberries. 
Citrus fruits and tomatoes may cause atopic allergy. 
Beverages 
Allergic actions are due to traces of foreign substances derived from food 
materials employed in the preparations or clarifying the beverage, such as  Barely 
malt and yeast in beer. 
Rye corn and wheat in whisky. 
  Fish, glue, egg white or yeast in cheap white wine and champagne. 
Food contaminants as allergens 
For example preservations, insecticides and insect excreta or fragments may 
act as allergens. 
Nor dihydroguairetic acid (NDGTA)  is an antioxidant used in food facts. 
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Cosmectics 
Common ingredients in cosmectics such as perfumes,nface creams, 
deodarents, hair dye, shampoos, parabens, benzocaine,lanolin, thimersol, etc. 
Clothing 
Rubber chappals, spectacle, resins, frames, furs, nylon, synthetic dyes. Most  
buton are formaldehyde resins, epoxy resins are all common sensitizers. 
Medicaments 
This include sulphonamides, penicillin, streptomycin, cocaine, tincture, 
benzoin, dettol, phenergon cream and sticking plaster, etc. 
Industrial and occupational agents 
Occupational 
Agriculturists : Plants, weeds, fertizers 
Automobile : Oil, petrol, solvent, grease, paints 
Building workers : 
Cement, lime, paints, insecticides, wood,   kerosene, 
turpentine oil. 
Chemical and pharmaceutical 
industries 
: 
Dyes, chemicals, explosives, solvents, disinfectants, 
detergents 
Coal miners : Mechanical injuires 
Dentists : Cocaine and its derivatives 
Engineering industries : Cutting oils, solvents 
Housewives : 
Soaps, detergents, vegetables, fruits, nickel, polishes, 
artificial flavours 
Nurses and doctors : Iodine, streptomycin, chlorpromazine, tincture, benzoin 
Photographers : Hardeners, solvents, glass, cellulose esters 
Rubber workers : Additives like TMT, MBT, dyes, glues, oils 
Tannery workers : Chromate, formaldehyde. Arsenic, alkalies, acids 
Textile workers : Formaldehyde, solvents, dyes, bleaches 
    
Ten common allergens come across in practice 
1. Paraphenylene diamine 
2. Nickel sulphate 
3. Potassium dichromate 
4. Parthenium hysterophorus 
5. Nitrofurazone ointment 
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6. Neomycin sulphate 
7. Formaldehyde 
8. Turpentine 
9. Garlic 
10. Epoxyresin 
Exacerbating factors 
Irritants   –           Physical, chemical or electrical 
Sensitizers   –           Plants, clothing, cosmetics 
                                      Medicaments, infection, diet and focal sepsis. 
External infections  –   Streptococci, staphylococci, fungus 
Diathesis   –       Allergic,xerodermic,hyperhidroticor seborrhoeic 
Drugs    –          State oflocal or general nutrition 
 Climate   –          Temperature and humidity 
Mental and emotional conflicts 
Internl septic focus shedding toxins or causing bacteraemia 
Scratching , chemical trauma, climate, stress and strains keep the process going with 
the result that eczema becomes chronic. 
It is still controversial whether the endogenous factors like diet, emotional strain and 
stress, focal sepsis, state of digestion, nutrition are more important than exogenous 
factors like infection, irritants and sensitizers (or) vice versa. 
In practice mixed eczemas are much more common than pure entities. History and 
clinical observation are very important in establishing the exact etiological diagnosis. 
Immunology 
Immunology is a science which deals with the body‟s response to antigenic 
challenge. 
This mechanism are involved in the protection of the body against infectious 
agents but periodically they can also cause damage 
Sensitization develops when a different clone of T- lymphocytes is activated. 
The sensitized T- lymphocytes yield two sub populations of lymphocytes. 
1. Memory cells that is responsible for the persistence of contact allergy. 
2. Effector cells that initiate the allergic response when appropriately 
challenged. 
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PATHOPHYSIOLOGY 
Allergy and hypersensitivity 
Both terms are synonyms 
The concept of hyper sensitivity was first introduced by portier and richet. 
The term allergy was first used by Von Pirquit (1874-1929) to denote changed 
reactivity of the body to outside chemicals. 
Changed reactivity in this context means that the body behaves in a particular 
way when it is exposed to a chemical substance known as „Allergen‟ for this first 
time, but changes the nature of its reaction when it is exposed for this first time, but 
changes the nature of its reaction when it is exposed for the second and subsequent 
times. This change is due to proteins known as antibodies. 
The moment, the allergen IgE combination stimulates the mast cells which 
unload their chemical contents into the surrounding tissues, these chemicals 
(mediators of allergy) cause the manifestations of allergy such as erythema, wheal and 
flare reaction, flare is due to dilation of arterioles by local axon reflex and the 
liberation of vasodilator substances like histamine and its by products like serotonin, 
bradykinin, acetylcholine from the injured cells like mast cells and basophils, etc., the 
manifestation of hypersensitivity may be immediate (or) delayed type 
Cutaneous allergy 
In the skin there are two important but different allergic reactions occur. 
Dermal reaction 
  Dermal reaction is commonly seen in urticaria. 
The causative antigen reaches the skin through ingestion, inhalation or 
injection of protein substances and the reacting antibodies, circulate in the serum. 
Allergic reaction takes place in dermis 
Intra drmal tests (scratch) shows reactivity 
Epidermal reaction 
 It is seen in allergic dermatitis or eczema 
The causative substance reach the skin by contact, intra dermal allergic tests 
are neagative. 
But patch test shows reactivity 
Allergen + epidermal protein – antigen formation(probably in lymph glands) 
Circulation – fixed in epidermal cells on next occasion 
Allergen + antibodies – eczematous reaction (In epidermis) 
48 
 
A severe local reaction may result in auto – intoxication and dissemination of 
eczematous reaction tom distant parts. 
Status eczematicus 
It is believed that in case of allergic states, a state  may develop when the 
patient becomes hypersensitive to even unrelated substances resulting in status 
eczematicus comparable to status asthmaticus in practice of internal medicine. 
Reaction time 
It is the time taken by asensitized individual to manifest  a clinical reaction 
following contact with a kown sensitizer. 
It is usually 12-24 hours but may vary from one hour to 120 hours. 
Dissemination reaction 
It is a fleeting erythematous macular reaction involving the face and flexures, 
caused by the escape of lymphokines in the circulation resulting in vasodialtion at 
distant site. 
Cause of recurrence 
Flare reaction is reactivation of a previously healed site of a contact dermatitis 
or a positive patch test reaction following renewed challenge or exposure to the same 
allergent at another site. This is because of persistence of sensitised lymphocytes at 
the site of earlier reaction , which react to minute amounts of antigen sometimes 
escape in the circulation form the new site and find its way to old site. 
Further it must be realised that dermal or epidermal sensitization affects the 
entire integument and this sensitization once acquired is lifelong. According to some , 
a degree of bloating in reactivity may be seen with the passage of time. 
Clinical features 
Eczema is a specific type of allergic subcutaneous manifestation of antigen 
antibody reaction. It is characterized by superifical inflammatory oedema of the 
epidermis associated with vesicle formation. Itching varies from mild to severe 
paroxysms which may even interfere with work and sleep. The natural history of 
eczema is represented as follows 
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History of eczema 
Erythema 
 
Papules with oedema  
 
Vesicles 
 
Weeping, crusting, pustules        lichenification 
 
Scaling 
 
Healthy skin without scars 
 
Histopathology 
1. Acute stage 
Itchy erthyema followed by oedema of the epidermis (spongiosis) papules, 
vesicles, oozing and crusting. 
This stage does not last long 
In about a couple of weeks, the lesions start to heal. If the cause persisits, and 
the eczema lasts over months or years. 
2. Chronic stage 
There is a less oedema 
Vesiculation, the integument appears thickened, and pigmented with 
prominent criss- cross(lichenification) markings. 
This is the end result of all types of long standing eczemas. 
This is accompanied by a variable degree of vasodilation and T- helper 
lymphocytic infiltration in the upper dermis. 
3. Sub acute stage 
Papules and scaling with moderate oedema and erythema 
Acute eczema may pass through this stage before it heals completely or 
become chronic. 
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CLASSIFICATION 
There are two groups of eczema 
Exogenous  Endogenous  
Irritant  Atopic  
Allergic  Seborrhoeic  
Photodermatitis  Discoid  
 Asteatotic  
 Gravitational  
 Neurodermatitis  
 Infectious eczymatoid  
 
Exogenous Eczema  
Irritant eczema 
Detergents, alkalies, acids, solvents and abrasive dusts are common causes. 
Irritant eczema accounts for the majority of industrial cases and work loss. 
The elderly, those with fair and dry skin and those with an atopic background 
are especially vulnearable. Napkin eczema in babies is common and due to irritant 
ammonical urine and feaces. 
Strong irritants elicit an acute reaction at the site of contact where as weak 
irritants most often cause chronic eczema, especially of the hands after prolonged 
exposure. 
Allergic contact dermatitis 
Definition 
Allergic contact dermatitis is an eczematous rash that develops after contact 
with an agent due to delayed cellular hypersensitivity. 
Aetiology (allergens) 
There are classified into two groups 
Non proteins – dyes, oils, resins, coal for  derivates, rubber, cosmetics and 
chemicals. 
Proteins – bacterial products, fungi and parasites are included in this group. 
Pathophysiology 
Allergic contact dermatitis results from a specific acquired hypersensitivity of 
the delayed type also know as cell mediated hypersentivity (or) immunity. 
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Occasionally dermatitis may be induced upon a sensitized area of skin when 
the allergic is taken internally and this occurs with substances such as anti histamines 
or sulphonamides. 
Persons may be exposed to allergens for years before finally developing 
hypersentivity. The sensitized area although usually generalized may be strictly 
localized. 
Eg:  Eczema of the ear lobes wrists and back due to contact with nickel in coustume 
jewellery. 
                                              Some common allergens 
Nickel  Jewellery, jean, stuels, bra clips 
Dichromate  Cement leather, matches 
Rubber chemicals  Clothing, shoes, tyres 
Colophony  Sticking plaster, collodion 
Paraphenylene diamine  Hair dye, clothing 
Balsam of peru  Perfumes, citrus fruits 
Neomycin, benzocaine  Topical applications 
Parabens  Preservative in cosmetics, and creams 
Wool alcohols Lanolin, cosmetics, creams 
Epoxy resin Resin adhesives 
Photo dermatitis 
Photo dermatitis means photo sensitization of the skin after contact with plants 
which have either photo toxic or photo allergic action. 
Dermatitis in this condition , is confined to the exposed parts of the body viz, 
face, neck, “v” of the chest, hands and external surfaces of the fore arms and dorsum 
of foot and the adjoining parts of legs, 
Foods like figs and buck wheat. 
External application of bithionol etc., 
Plants and theirproducts like parsnips, cow parsnips meadow grass mustards, 
lime oil, psoralea, bergamot oil, etc., 
Endogenous eczema 
There is no evidence of external irritants or allergens in endogenous eczema 
part of the body becomes sensitized to internal body products, toxins from focal 
sepsis, metabolites that are products of digestion (or) elements of diet and drugs with 
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or without familial predisposition to this list should be added psychosomatic 
influences 
Atopic eczema 
It is also called asthmatic eczema syndrome 
Atophy (out of – place – ness) is a genetic predisposition to form excessive 
IgE which leads to a generalised and prolonged hypersensitivity to common 
environmental antigens. 
Atopic individuals manifest one or more of a group of disease that includes 
asthma, hay fever, urticaria and this distinctive form of eczema. 
Aetilogy 
The inheritance of atopic eczema is controversial. The disorder is concordant 
in 86% of monozygotic twins but in only 21% of dizygotes, 
Atopic disease show maternal imprinting i.e., they are inherited more often 
from the mother than from the father. 
Pathogenesis 
It is best considered as interplay of genetic suspectibility that causes epidermal 
barrier dysfunction and abnormal immune responses, which are then stimulated by 
different environmental factors. 
Distribution and character of rash 
Infancy  
The eczema is often acute and involves the face and trunk. 
The napkin area is frequently spared. 
Childhood 
The rash, settles on the back of the knees, front of the elbows, wrists and 
ankles. 
Adults 
The face and trunk are once more involved lichenification is common. 
Diagnostic criteria 
Itchy skin and at least three of the following 
History of itch in skin creases (or cheeks if ^4 years) 
History of asthma / hay fever (or in a first – degree relative if ^ 4 years) 
Dry skin (xeroderma) 
Visible flexural eczema ( cheeks, forehead, outer limbs if ^ 4 years) 
Onset in first 2 years of life 
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 Complications 
Super infection most often with bacteria (staphylococcus aureus) but also 
importantly with viruses. Herpes simples virus causes a widespread severe eruption – 
eczema herpeticum. 
Papilloma virus and molluscum contagiosum super infections are also more 
common and are encouraged by use of local steroids. 
Irritants reactions due to defective barrier function. 
Sleep disturbances, loss of schooling, and behavioural difficulties. 
Children with atopic eczema have an increased incidence of food allergy, 
particularly to eggs, cow‟s milk, protein, fish, wheat and soya. 
These foods cause an immediate urticartial eruption rather than exacerbating 
their eczema. 
Seborrhic eczema 
 This condition which is characterised by a red scaly rash classically affects 
the scalp (dandruff) central face, nasolabial folds, eyebrows and cenral chest. 
It is due to pityrosporum ovale infection of the skin. 
In its milder forms it is the same as dandruff where as when severe it may 
resemble psoriasis. 
Sebum may be permissive for the development of the rash. 
Seborrhoeic eczema is a feature of AIDS and can be very severe in this 
condition. 
Discoid  eczema 
Synonym: nummular eczema 
This is a common form of eczema recognised by discrete coin shaped lesions 
of eczema seen on the limbs of young men associated with alcohol excess, and of 
elderly men. 
It can occur in children with atopic eczema and tends to be more stubborn to 
treat. 
Aetiology 
Psychogenic stresses 
Focal sepsis 
Food allergies 
Alcohol 
Debility and drugs 
54 
 
A dry skin and cold weather may be associated with it, sometimes it may be 
associated dyshidrosis of palms and soles, and discoid patches of keratoderma. 
Asteatotic eczema 
This is frequently seen in the hospitalized elderly especially when the skin is 
dry, low humidity caused by central heating over washing and diuretics are 
contributory factors. 
It occurs most often on the lower legs as a rippled or crazy paving pattern of 
fine fissuring on an erythematous background. 
Gravitational (stasis) eczema 
Persistant inflammation o the skin of the lower legs commonly associated with 
venous in competency. 
The eruption is usually localized to the ankle, where oedema, erythema, mild 
scaling and brownish discoloration occur. Secondary bacterial infection and eventual 
ulceration may occur. The cause is mainly due to perivascular fibrin deposition and 
abnormal small – vessel vaso constrictive reflexes. 
Neuro dermatitis 
Synonym: lichen simplex chronicus 
Affecting more commonly neurotic people. 
Definition 
This condition may be defined as the lichenification process resulting from 
chronic scratching and rubbing of the skin under stress and anxiety. 
Common amongst young people and menopausal women 
Clinical features 
The skin become thickened, infiltrated and pigmented. The criss cross 
markings become more prominent. Margins are irregular and usually well defined. 
Pathology and pathogenesis 
Histologically these may be striking hypertrophy of the  epidermis, which in 
extreme cases may resemble epitheliomatous change (pseudo epitheliomatous 
hyperplasia) there is also hyperkeratosis and variable amount of inflammation in the 
sub-epidermal zone. There is a marked increase in the role of epidermal cell 
production according for the hypertrophy and it is believed that the persistant tauma 
of scratching and rubbing is responsible for this. 
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Common sites 
The nape of the neck, arms, ano-genital area, back of kness, legs and ankles. 
Pompholyx (dyshidrotic eczema) 
Recurrent vesicles and bullae occur on the palms, palmer surface of the fingers 
and soles. 
It is most common in adult life(20-40) 
Provoking factors 
 Heat  
 Stress 
 Nickel ingestion 
But is often idiopathic. 
Infectious eczematoid dermatitis 
Synonym: Infective eczema 
This results from sensitization to certain organisms like streptococci, 
staphylococci, dermatophytes and yeast organisms. 
Clinical features 
Characterised by their slow development no vesiculation is usually evident a 
crust is formed instead. The patch or patches are sharply defined and there is no 
erythematous halo. 
Sites: Body folds, hair follicles. 
Sub divisions 
1. Post traumatic infective eczema 
It starts with a crack in the integrity of the skin brought on by an injury, a 
blister an insect bite or exposure to a cold wind, etc. 
Eczematizaion secondary to acute tinea, particularly tinea. Pedis is frequently 
seen. It starts from digital spaces and spreads to the dorsum of the foot or the 
soles. 
2. Follicular infective eczema 
It involves hairy region like the scalp, beard and legs. It starts usually with 
pityriasis capitis which gets complicated by one (or) several itchy patches f 
oozing, pits and crusting. The eczema spread to fore head, retro auricular folds 
and cheeks. Streptococci, staphylococci an less so pitryosporon organism are 
the caustives. 
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3. Flexural infective eczema 
The flexures are thesites of predilection. It starts with a crack in the depth of 
the fold and two opposing surfaces are equally affected. The inner part looks 
moist and red only at the periphery is crusting clearly evident. 
Infantile eczema 
This occurs in children between the ages of the ages of the three months and 
two years. It usually starts on the cheeks, spreading slowly to forehead, chin, 
scalp, arms, trunk, legs, buttocks and in the groins, napkin rash like dermatitis 
may develop. 
Etilogy 
Dietetic allergies mayplay an  important role in the causation. 
 
Clinical features 
 Characterized by erythema, vesicles, exudation and crusting pruritis is a 
prominent symptom, it comes in spasms. To start with the infants are usually 
plump. 
Types 
1. With high familial predisposition to an allergic disease – the atopic variety. 
2. Without familial predisposition – simple variety. 
Investigation of eczema 
Patch test  
 Patch tests detect type IV (delayed or cell- mediated) hypersensitivity. 
It is common practice for a battery of around 20 common antigens, including 
common sensitizers such as nickel, rubber and fragnance mix to be applied to the skin 
of the back under aluminium discs for 48 hours. 
The sites are then examined for a positive reaction 24 hours later and possibly 
again a further 24 hours later 
The positive test is revealed by the development of an eczematous patch with 
erythema swelling and vesicles at the site of application. 
Patch test reaction is graded in the following degrees 
+  -  Only redness 
++ -  Marked redness and swelling 
+++  -  Marked redness, swelling and papules  
++++  -  Medness, oedema and vesicles 
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Specific IgE 
Specific IgE levels to antigens can be measured in serum by a specific radio 
allergic sorbent test (RAST). 
These are occasionally performed to support diagnosis of atopic eczema and to 
determine specific environmental allergens, eg: Pet dander, horse hair, house dust 
mite, pollens and foods. 
Prick tests 
Prick tests are a way of detecting cutaneous type I (immediate) 
Hypersensitivity to various antigens such as polen, house dust, mite or dander. 
Bacterial and viral swabs for microscopy and culture 
These are useful tests in suspected secondary infection skin swabs for 
bacteriological assessment will invariably reveal the presence of bacteria. In the case 
of recurrent impetigo in a child with atopic eczema, bacterial swabs should be taken 
from carrier sites ( axillae and groin) from both the affected individual and house hold 
members. 
Hints diagnosis for all eczemas 
1. Nature of the lesions – size, shape, itching, number of papules,pustules, 
erythema etc., 
2. Distribution – sites of lesion. 
3. History of occupation 
4. History of exposure to allergens – i.e. chemicals, plants, soap, etc., 
5. Personal and family history of such disease – eg: atopic or allergic eczemas. 
6. Climate – eg: dyshidrosis  occurs at the change of seasons particularly in 
spring, summer. 
7. Patch test (allergy test) in allergic/ atopic eczemas. 
8. Biopsy in rare cases when the lesions do not respond to treatment. 
Prognosis of eczema 
Dermatitis and eczema are s rule curable conditions. Eczema are ineffective 
except when they are leave scars. The patient needs reassurance of these points. 
It must be remembered that epidermis is an ectodermal structure and so takes 
time to heal. Energetic treatment is to be strongly discouraged. 
Acute eczemas heal readily in about 1-4 weeks with treatment. 
Chronic eczemas in which anatomical and functional changes set in take time 
to disappear. 
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Disseminated and generalized eczemas are not only slow to heal,but are 
accompanied by ill health, infantile and atopic  eczemas are trouble some and 
uncomfortable. 
The former lasts till the age of twenty five or even though life. Its course is 
marked by spontaneous remissions and exacerbations. 
Psychogenic stresses climate extremes and poor health aggravate eczema. The 
cure of these conditions is retarded in tropical countries by heat, humidity and the 
prevalent unhygienic conditions 
General lines of managements 
1. Explanation and reassuring the patient 
2. Psychotherapy – counseling and antidepressants mild sedatives learn to live 
with it, anger, frustration avoided. 
3. Correcting or eliminating the aetiological factors. 
4. Exposure to sunlight or extremes of climate to be avoided, change of place or 
A/C advised. 
5. Scratching and rubbing to be avoided, the nail to be cut abort. 
6. The health of teh patients is improved by multivitamins, iron, protein. 
7. Be aware of any foods that may cause an outbreak and avoid those foods. 
8. Avoid harsh soaps, detergents, and solvents. 
9. Avoid environmental factors that trigger allergies pollens, molds, mines, and 
animal dander. 
10. Rest to the affected part or bed rest for generalized eczemas. 
11. Protection of the affected part – cotton bandage, glove or mask. 
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MATERIALS AND METHODS 
 The clinical study on karappan was carried out in the outpatient and inpatient 
ward of government siddha medical college hospital palayamkottai. 
Approach towards the patients was made according to the signs and symptoms of 
karappan as mentioned in siddha aspects 
SAMPLE SIZE : 
 40 patients (OPD& IPD) 
STUDY DESIGN & CONDUCT OF STUDY:  
Study type  :  prospective open labelled phase II  clinical 
criteria based study . 
Study Place :  OPD & IPD of Government Siddha medical College 
& hospital,   Palayamkottai. 
Study Period :  24 Months  
Sample Size :  40 Patients (OPD& IPD). 
Inclusion 
1. Age between 18 – 60 years 
2. Both sex 
3. Symptoms 
. Erythema 
. Papules 
. Intense itching 
. Recurring rash 
. Scaly rash 
. Oozing 
. Hypoand hyper pigmented patches of skin 
Exclusion 
1. Psoriasis 
2. Fungal infection 
3. Scabies and other infestation 
4. Pregnancy women and lactating mothers 
5. Bedridden patient for severe illness. 
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WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of adverse reactions during drug trial. 
 Poor patient‟s compliance and defaulters. 
 Patient turned unwilling to continue in the course of clinical trial.  
 Occurrence of any serious illness.  
TESTS AND ASSESMENTS: 
 Clinical assessment  
 Routine investigations 
 Specific investigations 
 Siddha investigations 
A detailed clinical history was taken by regarding the following signs and symptoms. 
 Duration of illness 
 Family history 
 Itching 
 Oozing 
 Pre disposition factors 
Siddha diagnosis was made with the help of the following criteria 
A case sheet was prepared on the basis of siddha methodology 
 Poriyal arithal 
 Pulanal arithal 
 Vinathal 
 Envagai thervugal 
 Ezhu udal kattugal 
 Thinai 
 Paruva kaalam 
Besides an individual case sheet was maintened for each case in ward. 
In modern system of medicine the following investigations were done. 
Skin examination 
 Site 
 Shape 
 Colour 
 Size 
 Border 
 Itching 
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 Erythema 
 Macule 
 Papule. 
Routine laboratory investigation 
Haematological investigation 
  Blood 
 .Hb 
 Total WBC count 
 Differential WBC  count 
 Neutrophils 
 Lymphocytes 
 Eosinophils 
 Monocytes 
 Basophils 
 Total RBC count 
 ESR 
 ½ Hr 
 1 Hr 
 Blood sugar 
 Random 
 Fasting 
 Postprandial 
Urine 
 Albumin 
 Sugar 
 Deposits 
Stool examination 
 Ova 
 Cyst 
 Rbc and puscells 
 
Investigations based on siddha system 
1. Naa 
2. Niram 
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3. Mozhi 
4. Vizhi 
5. Malam 
6. Moothiram 
7. Sparisam 
8. Naadi 
 Neerkuri 
 Neikuri 
TREATMENT   : 
 Vellaiennai 15ml at morning with hot water was given on the first day of 
treatment. 
INTERNAL: 
Drug: Kukkiladhi chooranam 
REFERENCE: 
 Virana karappan roga sigichai pg: 264 
DOSE: 
800-1000 mg, (twice a day). 
DURATION: 
48  Days 
ADJUVANT: 
 Hotwater 
EXTERNALDRUG: 
 Karappanuku Ennai 
REFERENCE: 
 Virana karappan roga sigichai pg:248 
EXTERNAL THERAPY 
 
VETHU: Vembu 
 
REFERENCE: 
 Siddhar aruvai maruthuvam pg: 41, 42 
Sidda maruthuva sirappu pg: 247-252 
Gunapadam mooligai vagupu pg: 561, 303, 470, 514. 
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OBSERVATION AND RESULTS 
 
Results were observed with respect to the following criteria: 
 Sex difference 
 Age Distribution 
 Kaalam distribution 
 Thegi 
 Occupational status 
 Socio economic status 
 Diet reference 
 Seasonal reference 
 Thinai Reference (Land and Place) 
 Gunam reference (Characters) 
 Mode of onset 
 Aetiological factors 
 Clinical features 
 Duration of Complaints 
 Distribution of uyir thathukal 
 Derangement of pitham 
 Derangement of kapham 
 Ezhu udar kattugal 
 Envagai thervugal 
 Neerkuri, neikuri reference 
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1. Sex difference 
S.No Sex difference No. of cases Percentage 
1. 
2. 
Male 
Female  
22 
18 
55% 
45% 
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2. Age Distribution 
Out of 40 cases, most of them were belonged to 51 – 60 age group. 
S.No Age No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
16 –20 
21 – 30 
31 – 40  
41 – 50 
51 – 60  
Above 60 
5 
1 
6 
13 
15 
-- 
12.5% 
2.5% 
15% 
32.5% 
37.5% 
-- 
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3. Kaalam distribution 
Different age groups were treated out of the 40 cases, most of them were in the pitha 
kaalam. 
S.No Kaalam No. of cases Percentage 
1. 
2. 
3. 
Vatha kaalam(1-33) 
Pitha kaalam(34-66) 
Kaba kaalam(67-100) 
9 
31 
--- 
22.5% 
77.5% 
--- 
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4. Thegi 
Out of 40 cases, most of them are were belonged to pithavatham. 
S.No Thegi No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
Vatham   
Pitham 
Kabam  
Vathapitham 
Pithavatham  
9 
8 
3 
4 
16 
22.5% 
20% 
7.5% 
10% 
40% 
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5. Occupation 
Occupational history is closely associated with karppan disease. Detailed history 
about the nature of workhas interrogated and illustrated as follows. 
S.No Occupation No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7 
8. 
9. 
Painter 
Tailor  
Teacher 
Housewife 
Mechanic 
Cooli 
Student 
Carpenter 
Driver  
3 
5 
4 
4 
2 
11 
5 
5 
1 
7.5% 
12.5% 
10% 
10% 
5% 
27.5% 
12.5% 
12.5% 
2.5% 
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6. Socio economic status 
The incidence of the disease was found to be higher in lower economic groups. 
 
S.No Socio-economic status No. of cases Percentage 
1. 
2. 
3. 
Poor  
Middle 
Rich  
34 
6 
- 
85% 
15% 
- 
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7. Diet reference 
Cases were enquired of their dietary habits, it was noted that 90% cases were 
non – vegetarian and 10%were vegetarian. 
 
S.No Diet habit No. of cases Percentage 
1. 
2. 
Vegetarian 
Mixed  diet 
4 
36 
10% 
90% 
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8. Seasonal reference 
When these 40 cases were enquired with that of the seasonal link, with occurencee 
and severity of this disease, no specific findings were reported except in a few cases. 
 
S.No Kaalangal No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
Munpani  
Pinpani 
Elavenir 
Muthuvenir 
Kaarkalam 
Koothirkalam  
17 
3 
- 
6 
4 
10 
42.5% 
7.5% 
- 
15% 
10% 
25% 
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9. Thinai 
Out of 40 cases, most of them were belonged to marutham. 
S.No Nilam No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
Kurinji 
Mullai 
Marutham 
Neithal 
Paalai  
-- 
1 
33 
6 
-- 
-- 
2.5% 
82.5% 
15% 
-- 
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10. Gunam 
Out of 40 cases, 77.5%  had rasogunam, 22.5%  had sathuva gunam. 
S.No Gunam No. of cases Percentage 
1. 
2. 
3. 
Sathuvam 
Rasogunam 
Thamogunam  
9 
31 
-- 
22.5% 
77.5% 
-- 
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11. Mode of onset 
Out of 40 cases 75% were found chronic sufferers 
 
S.No Mode of onset No. of cases Percentage 
1. 
2. 
3. 
Acute 
Sub – acute 
Chronic  
4 
6 
30 
10% 
15% 
75% 
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12. Aetiological factors 
When the 40 cases taken for study were observed , occupational status, poor 
hygiene, incompatible diet, anxiety and family history were found clinically 
contributable to the severity of the illness. The incidents were as follows 
 
S.No Diet habit No. of cases Percentage 
1. 
2. 
3. 
4. 
Occupational status 
Incompatible diet 
Positive family history 
Psychological stress 
26 
4 
6 
4 
65% 
10% 
15% 
10% 
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13. Clinical features 
Regarding the signs and symptoms of karappan 
 
S.No Clinical features No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10 
11. 
Constipation  
Erythema  
Itching 
Vesicles 
Oedema 
Pustules 
Oozing 
Scaling 
Pain 
Ulcers 
Lichenification  
6 
22 
40 
34 
25 
14 
36 
15 
26 
20 
2 
15% 
55% 
100% 
85% 
62% 
35% 
90% 
37.5% 
65% 
50% 
5% 
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14. Duration of Complaints 
 
S.No Duration of complaints No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
2 years 
1year 
10 months 
8 months 
6 months 
5 months 
4 months 
3 months 
2 months 
2 
3 
1 
2 
7 
2 
1 
16 
6 
5% 
7.5% 
2.5% 
5% 
17.5% 
5% 
2.5% 
40% 
15% 
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Distribution of uyir thathukal 
The dearangement of thathu in karppan is tabulated as follows 
15. Derangement of vatham 
S.No Vatham No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Piranan 
Abanan 
Viyanan 
Uthanan 
Samanan 
Nagan 
Koorman 
Kirukaran 
Devathathan 
Thanajeyan  
-- 
15 
38 
-- 
40 
-- 
-- 
-- 
12 
-- 
-- 
37.5% 
95% 
-- 
100% 
-- 
-- 
-- 
22.5% 
-- 
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16. Derangement of pitham 
S.No Pitham No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
Anar pitham 
Ranjagam 
Sathagam 
Alosagam 
Prasagam 
1 
17 
40 
-- 
40 
2.5% 
42.5% 
100% 
-- 
100% 
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17. Derangement of kapham 
S.No Kapham No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
Avalambagam 
Kilethagam 
Pothagam 
Tharpagam 
Santhigam  
-- 
-- 
-- 
-- 
6 
-- 
-- 
-- 
-- 
15% 
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18. Ezhu udar kattugal 
The seven udar kattugal which contribute for the normal body structure, get changed 
in pathological conditions. They were tabulated below. 
S.No Type of udar kattugal No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
Saaram 
Senneer 
Oon 
Kozhuppu 
Enbu 
Moolai 
Sukkilam/suronitham 
40 
40 
15 
-- 
15 
-- 
-- 
100% 
100% 
37.5% 
-- 
37.5% 
-- 
-- 
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19. Envagai thervugal 
In the siddha system of medicine eight investigative procedures were handled for a 
clinical approach and diagnosis. These methods were strictly followed in all the cases 
and observations were noted. 
S.No Type of investigations No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
 
 
8. 
Naa 
Niram 
Mozhi 
Vizhi 
Malam 
Moothiram 
Naadi 
a) Vatha pitham 
b) Pitha vatham 
Sparisam  
-- 
40 
-- 
-- 
16 
-- 
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-- 
100% 
-- 
-- 
40% 
-- 
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20. Neerkuri, neikuri reference 
S.No Type of test No. of cases Percentage 
1. 
2. 
Neerkuri 
Neikuri 
 Vatha neer 
 Pitha neer 
Kaba neer 
40 
 
36 
2 
2 
100% 
 
90% 
5% 
5% 
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DISCUSSION 
For this dissertation study totally 40 cases were treated both in out patient 
ward and inpatient ward of Government Siddha Medical College, Palayamkottai.  
The triggering factors like the climate influences, psychological disturbances, 
etc., were also studied. Daily observations were made before, during and at the end of 
the study. The observations are discussed as follows. 
Sex distribution 
In the study among the forty cases, 55% were males and 45% were females. 
According to the siddha literatures there is no apparent sex predilection in karappan. 
Age distribution 
During this entire study, the prevalence of  Karappan was a very common one 
affecting the adult age group mainly above 50 years.  
Kaalam (Life Span) distribution:  
 Out of 40 patients 
 77.5% of the patients belonged to Pitha kaalam 
 22.5% of the cases belonged to Vatha kaalam 
 These research study shows that more patients were affected in their pitha 
and vatha kaalam. 
Occupational status 
Occupational hazards play an important role in causing or aggravating the 
disease Karappan. This matter is almost true in the cases as their relevant occupational 
histories were drawn from all the patients.  
Socio – economic condition 
Out of Forty patients, 85% were belonged to poor economic conditions, 
Majority of them were ignorant in personal hygiene. Malnutrition, prolonged & 
persistent exposure to polluted atmosphere, lowered immune responses made them 
prone to this type of disease. 
Diet Reference 
According to siddha literature the non-vegetarian accounts much more for the 
occurrence of the Karappan. Here during the study 90% of patients were mixed 
dietary habits. Again some food stuffs like raggi, bitter guard, brinjal, maize, tomato 
and fish items can also be causative factors for the karappan. So they were advised to 
avoid such food items. 
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Seasonal reference 
 Skin diseases prone to have definite seasonal influences. Out of 40 cases,  
  10% belongs to Kaar kaalam (August to October)   
 25% belongs to Koothir Kaalam  (October to December) 
 15% belongs to Muthuvenil Kaalam (June to August) 
  42.5% belongs to munpani kaalam (December to February) 
 7.5% belongs to pinpani kaalam ( February to April) 
Thinai reference (Land and place) 
82.5% of cases belonged to marutha nilam. This may be due to the 
environmental pollution caused by the advancement of science & technology, life 
style and the uses of too much of pesticides and chemicals. 
Gunam reference   
Out of 40 cases, 77.5%cases had Rajogunam, 22.5% cases had sathuva gunam. 
From this inference character is very much important in developing disease. This was 
clearly stated in the siddha system. So control of mind and restoration of normal life 
style can lead to reduction in the formation of disease. 
Mode of onset 
During the study 75% cases were observed to be the chronic onset. Incomplete 
treatment, failure to follow medical advice and dietary restrictions, psychological 
strains and changed life style were observed to be the reasons for this disease to 
become chronic.  
Three dosha reference 
a) Vatha reference 
Abanan was affected in 40% cases (habitual constipation). Viyanan was 
affected in 95% cases(), Samanan were affected in all 100% cases (due to affected of 
other vatha thosha). Devathathan was affected in 20% cases (laziness) 
b) Pitha reference 
Anarpitham was affected in 6 cases (loss of appetite, indigestion) Ranjagam 
was affected in 47.5% cases (low Hb level) Alosagam was affected (senile cataract) in 
8 cases .Sathagam was affected in all 100% cases (difficult in day to day activity). 
Prasagam was affected 97.5% cases (due to pigmentationof skin). 
c) Kapha reference 
    Santhigam (joint pain) was affected in 15% cases.  
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Ezhu (seven) Udar Kattugal reference:  
Among the 7 udar kattugal, saaram was affected in 100% cases   (depression, 
anhidrosis, etc) senneer was affected in 100% of cases (papules, vesicles, lassitude, 
anemia).  Both oon and kozhuppu were affected in 37.5% cases. 
Envagai Thervugal reference 
In Envagai thervugal niram and sparisam were affected in all cases.  Malam 
was affected in 40%.  Regarding to Naadi nadai, vatha pitham was found in 47.5% 
cases and pitha vatham was found in 52.5% cases. 
Mode of action 
Each and every drug contains five kind of actions i.e suvai (Rit), gunam 
(Fzk;)> veeriyam (tPhpak;)> pirivu (gphpT) and mahimai (kfpik) All these five are 
based on five elements (pancha boothas) which are present in the drug. 
Normalization of these 3 thathus (Vatha, Pitha, Kapha) is a cure to the disease. 
Karappan occurs as a result of derangement of Kapham. Kukkiladhi chooranam 
actually brings the deranged kapham to normal. 
40 patients were admitted in the inpatients and outpatients ward to facilitate 
frequent supervision. All the patients were treated with kukkiladhi chooranam 
internally and karappanukku ennai externally for an average of 20 days. The 
improvement was observed from the third day onwards in acute and sub actue cases, 
8-10days in chronic cases. The number of days taken for complete disappearance of 
the symptoms varied from case to case. 
In this study, kukkiladhi chooranam (internal) and Karappanukku ennai 
(external) were found to be more effective in clinically.  
The author has chosen the drugs for their specific effect on the lines of the 
siddha principles and also to find out the clinical constituents of the drugs on the basis 
of modern chemical analysis. 
The result of the pharmacological study is concluded that the kukkiladhi 
chooranam has 
 Significant anti histamine action. 
 Significant anti inflammatory action. 
 Significant toxicological action 
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Karappanukku ennai has  
 Significant acute anti inflammatory action. 
It is a pleasure to say that there was no report of adverse effects during the 
entire course of treatment in all cases. 
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SUMMARY AND CONCLUSION 
 The description about the aetiology, types, pathogenisis and clinical features of 
Karappan were found in many Siddha Literatures. 
 40 cases from both sexes of different age groups were selected from both Out 
patients and In patients. 
 Before starting the treatment careful detailed history was carried out and recorded. 
 They were treated with „Kukkiladhi chooranam’ internally and „karappanuku 
ennai’ externally. 
 Along with medication the patients were advised over their dietary habits. 
 History, clinical findings, laboratory results, Envagai thervugal and uyir 
thathukkal were used for the diagnostic purpose.  
 The general improvements in the condition of the patients were observed from the 
end of the first week itself. In an average of 20 days treatment, all the patients 
showed satisfactory relief generally. 
 Most of the patients had showed quite encouraging progress. 
 The observations made during the clinical study shows that the internal drug is 
clinically very effective.  
 The action of external applications is also quite remarkable. 
 The drugs were found to be free from adverse effects during the entire course of 
treatment. 
 The herbs are available in almost all season and preparation of medicine is very 
simple. 
 Finally the ingredients of this trial drugs are very economic. 
These merits are essential in promoting this drug in future globally. Here by 
the author concludes that the skin disease “ Karappan” can be better treated with the 
trial drugs. 
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DRUG - REVIEW  
PREPARATION OF TRIAL DRUGS 
INTERNAL MEDICINE 
KUKKILADHI CHOORANAM 
 DRUG NAME BOTANICAL NAME USED PART QUANTITY 
1 CHUKKU ZINGIBER OFFINALIS RHIZOME 35g 
2 MILAGU PIPER NIGRUM DRY FRUIT 35g 
3 THIPPILI PIPER LONGUM DRY FRUIT 35g 
4 KARUNSERAKAM NIGELLA SATIVUM DRY SEED 35g 
5 KUKKIL SHOREA ROBUSTA RESIN 175g 
6 VELLARUGU ENICOSTEMMAAXILLARE WHOLE 
PLANT 
105g 
 
METHOD OF PREPARATION: 
 The above 1-6 ingredients are grinded and mixed together. 
DOSE: 
 800 - 1000mg 
VEHICLE: 
 Hot Water 
BOOK NAME: 
 Viranakarappan roga sigichai 
PAGE NO: 264 
EDITION: THIRD 
PUBLICATION: Saraswathi mahal noolaga printer 
1. Rf;F: Chukku 
 Botanical Name : ZINGIBER OFFICINALE 
 Family  : ZINGIBERACEAE 
 Parts used  : fpoq;F (cyh;e;jJ) 
 Rit   : fhh;g;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
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nra;if: 
 ntg;gKz;lhf;fp (Stimulant) 
 grpj;jPj;J}z;b (Stomachic) 
 fl;Ltha;tfw;wp (Carminative) 
Chemical Constituents: 
 Anti oxidant components were polyphenols, Vitc, -sitosterol, 
palmitate, isovanillin, glycol monopalmitate, hexacosanoic acid 2,3 - 
dihydroxypropyl ester, maleimide - 5-oxime, p-hydroxy benzaldehyde, 
adenine, 6-gingerol, 6-shogaol, 1-(omega0ferulyloxyceratyl) glycerols 
 
 Free amino acids include glutamic acid, aspartic acid, serine, glycine, 
thereonine, alanine, glutamine, arginine, -aminobutyric acid, valine, 
phenylalanine, asparagine, lysine, cystine, histidine, leucines, proline and 
pipecolic acid. 
 
Fzk;: 
  #iyke;jk; neQ;nrhpg;G NjhlNkg; gk;koiy 
  %yk; ,iug;gpUky; %f;FePh; - thyRg 
  Njhlk;jp rhue; njhlh;thj Fd;kePh;j; 
  Njhlk;M kk;Nghf;FQ; Rf;F 
 Rf;fpdhy; nrhpahik> khh;nghpr;ry;> GspNag;gk;> ntg;gk;> fPo;tha; 
Neha;> ,iug;G> ,Uky;> fopr;ry;> ePNuw;wk;> Fd;kk;> tapw;Wg;gprk;> 
fhJf;Fj;jy;> KfNeha;> jiyNeha;> Fiytyp> ghz;L> tapw;Wf; Fj;jy;> 
Ia Ruk; Nghk;. 
2. kpsF - Milagu 
 Botanical Name : PIPER NIGRUM 
 Family  : PIPERACEAE 
 Parts used  : tpij> nghb 
 Rit   : ifg;G> fhh;g;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
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nra;if: 
 mfw;Wtha;tfw;wp (Carminative) 
 Kiwntg;gfw;wp (Antiperiodic) 
 jbg;Gz;lhf;fp (Rubefacient) 
 ntg;gKz;lhf;fp (Stimulant) 
 tPf;fq;fiur;rp (Resolvent) 
 thjklf;fp (Antivatha) 
 er;rhp (Antidote) 
 
Chemical Constituents: 
 Piperine, α-tocophenol, α - pinene, -caryophyllene, -pinene, -
eudesmol, Limonene, Delta - 3 carene, Sabinene, Eugenol, Terpenin - 4-ol, 
Hedycaryol, Caryophyllene oxide. 
 Phytochemicals includes amides, piperidines, Pyrrolidines and trace 
amounts of safrole. 
 Also contains lysine, histidine and cystine 
Fzk;: 
  msitAwhf;fhuk; mile;jpUf;Fk; thj 
  tpisitnay; yhkWf;Fk; nka;Na - kpsfpd;fha; 
  fz;lth;f;Fk; ,d;gkhk; fhhpifNa! rPo;Kyq; 
  nfhz;lth;f;F ed;kUe;jhq; $W. 
   ,J tsp Neha;fisAk; rPo; %yj;ijAk; ePf;Fk; 
3. jpg;gpyp: Thippili 
 Botanical Name : PIPER LONGUM 
 Family  : PIPERACEAE 
 Parts used  : fha;> mhprp 
 Rit   : ,dpg;G 
 jd;ik  : jl;gk; (gr;ir) 
    : ntg;gk; (cyh;e;jJ) 
 gphpT   : ,dpg;G 
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nra;if: 
 ntg;gKz;lhf;fp (Stimulant) 
 mfl;LthAtfw;wp (Carminative) 
Chemical Constituents: 
 Compounts are piperidine, pirrolidine, turmerone, methanol, aphanamol, 
bisdemethoxycurcumin, demethoxycurcumin. 
 Alkaloids are piperine, piplartine, triacontane, dihydrostigmasterol, 
reducing sugar, piperlongumine, piperlonguminenine 
Fzk;: 
 fl;b najph;epd;W fLNehnay; yhk;gzpAk; 
 jpl;b tpidafYk; Njfnkj;j - Gl;bahk; 
 khkDf;F khkndd kw;wth;f;F kw;wtdhq; 
 fhknkDe; jpg;gpypf;Fk; if 
 fLikahd Iag;gpzpfis mfw;wp> clw;F td;ikia mspj;jpLk; 
4. fUQ;rPufk;: Karunserakam 
 Botanical Name : NIGELLA SATIVA 
 Family  : RANUNCULACEAE 
 Parts used  : tpij 
 Rit   : ifg;G> Jth;g;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
nra;if: 
 mfl;Ltha;tfw;wp (Carminative) 
 rpWePh;g;ngUf;fp (Diuretic) 
 UJTz;lhf;fp (Emmenagogue) 
 ghw;ngUf;fp (Galactogogue) 
 GOf;nfhy;yp (Anthelminitic) 
 grpj;jPj;J}z;b (stomachic) 
 J}f;Fzpg;GOf;nfhy;yp (Parasiticide) 
 twl;rpafw;wp ((Encollient) 
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Chemical Constituent: 
 Phenolic compounds are thymoquinone, dithymoquinone, 
thymohydroquinone and thymol. 
 Compounds are nigellin, tannin, resin, protein, reducing sugar, saponins, 
arabic acids. 
 Free amino acids present are cystine, lysine, aspartic acid, glutamic acid, 
alanine, tryptophan, valine, leucine. 
Fzk;: 
 fUQ;rP ufj;jhd; fug;ngndhL Gz;Zk; 
 tUQ;rpuha;g; gPerK khw;Wk; - mUe;jpdhy; 
 fha;r;ry; jiytypAq; fz;typAk; NghKyfpy; 
 tha;r;r kUe;njdNt it 
 fug;ghd;> Gz;> cl;#L> jiyNeha;> fz;Nzha; ,itfSk; rpuq;F> 
tapw;Wg; nghUky;> Fd;kk;> khh;G typ> ,Uky;> the;jp> Xf;fhsk;> tPf;fk;> 
fhkhiy MfpaitfSk; fUQ;rPufj;jhy; ePq;Fk;. 
5. Ff;fpy;: Kukkil 
 Botanical name : COMMIPHORA MUKUL 
 Family  : BURSERACEAE 
 Parts used  : gprpd; 
 Rit   : Jth;g;G> ifg;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
 
nra;if: 
 mfl;Ltha;tfw;wp (Carminative) 
 UJTz;lhf;fp (Emmenagogue) 
 ,rptfw;wp (Antispasmodic) 
 
Chemical Constituents: 
 Guggulsterone 
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Fzk;: 
  Ff;FY Jth;f;ifg; ghFk; 
   tpad;jUq; fpUkp nfhy;Yq; 
  Ff;f Nuhfq; fzNkfq; 
   Fd;k Nrhig fise;jPh;f;Fk; 
  nka;f;fpue;jp tpisg;G\;z 
   Ntfj;ijg; Nghf;F Nkgh 
  yf;fpu fq;f Nshl;Lk; 
   gplh;typ khw;W lhNj! 
 fpUkpfis mopf;Fk; fzNkfk;> Fd;kk;> Nrhig ,tw;iwj; 
jPh;f;Fk; fpue;jp> c\;zNtfk; ,tw;iwg; Nghf;Fk;. ghyf;fpufq;fis 
ePf;Fk;. 
 
6. nts;sWF: Vellarugu 
 Botanical Name : ENICOSTEMMA AXILLARE 
 Family  : GENTIANACEAE 
 Parts used  : G+z;L 
 Rit   : ifg;G 
 jd;ik  : ntg;gk; 
 gphpT   : fhh;g;G 
 
nra;if: 
 grpj;jPj;J}z;b (Stomachc) 
 cukhf;fp (Tonic) 
 clw;Nww;wp (Alteratie) 
 kykpsf;fp (Laxative) 
 ntg;gfw;wp (Febrifuge) 
 
Chemical Constituents: 
 Phenolic acids like vanillic acid, syringic acid, p-hydroxy benzoic acid, 
protocatechuic acid, p-coumaric acid, ferulic acid and also contain ophelic acid. 
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Fzk;: 
 Fd;knkhL tha;T Fly;thjk; #iyapit 
 nrd;kk;tpl; Nlhbr; rpijAq;fhz; - td;Kiyaha; 
 cs;SWfp ue;jpnrhwp nahl;ba rpuq;FkWk; 
 nts;sWF jd;id tpUk;G 
 
 ,jw;F Fd;kk;> tspNeha;> Fly; thA> fPy; gpbg;G> euk;Gfisg; 
gw;wpa foiy> jpdT> rpWrpuq;F Mfpait Nghk;. 
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EXTERNAL MEDICINE 
KARAPPANUKU ENNAI 
 DRUG NAME BOTANICAL NAME PART 
USED 
QUANTITY 
1 NANNARI VER HEMIDESMUS INDICUS ROOT 4.16gm 
2 SANGAM VER AZIMA TETRACANTHA ROOT 4.16gm 
3 PERUMARUNTHU VER ARISTOLOCHIA INDICA ROOT 4.16gm 
4 AAVARAI VER CASSIA AURICULATA ROOT 4.16gm 
5 NERUNJIL VER TRIBULUS TERRESTRIS ROOT 4.16gm 
6 NATHAICHOORI VER BORRERIA HISPIDA ROOT 4.16gm 
7 VELLAIPUNDU ALLIUM SATIVUM RHIZOME 4.16gm 
8 VASAMBU ACORUS CALAMUS ROOT 4.16gm 
9 AMANAKKU ENNAI RICINUS COMMUNIS SEED 280gm 
 
METHOD OF PREPARATION: 
 The above 1-8 ingredients are powdered and mixed together as rules and then 
added to the amanakku ennai in a vessel boiled on gentle fire and filtered. 
INDICATIONS 
 Karappan wounds 
BOOK NAME 
 Viranakarappan roga sigichai 
PAGE NO  : 248,249 
EDITION   : Third 
PUBLICATION : Saraswathi mahal noolaga printer 
ed;dhhp Nth; - Nannari Ver 
Botanical name : Hemidesmus indicus 
g-c   : Nth; 
Rit   : ,dpg;G> rpWifg;G> 
jd;ik   : jl;gk;  
gphpT   : ,dpg;G 
nra;if: 
 clw;Nww;wp  tpahjhNgjfhhp  Alterative 
 cukhf;fp  gyfhhp   Tonic 
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 cs;soyhw;wp me;jh;];epf;jfhhp  Demulcent 
 rpWePh;g;ngUf;fp %j;jputh;j;jpdp  Diuretic 
 tpah;itg;ngUf;fp ];Ntjfhhp   Diaphoretic  
Chemical constituents 
Hexatriacontane 
Lupeol 
Octacosanoate 
Acetate 
Sitosterol 
Hemidesminine 
Hemidesmin I 
Alpha amyrin 
Beta amyrin. 
 
Fzk; 
ryNjhlk; gpj;jkjp jhfk; - coiy 
  ryNkW rPjkpd;dhh; jQ;#-Lyfkjpw; 
  nrhd;dkJ Nkfk; Gz; Rukpitna yhnkhopf;Fk; 
  nkd;kJu ed;dhhp Nth;  (Nj.F.) 
     ed;dhhp 
  mq;fh hpif%yp ahr;rpaj;Njh Lz;zepj;jp 
  aq;fh hpif%yp ahSNk - aq;fhhp 
  gw;whJ    (Nj.a.-nt) 
 
rq;fd; Nth; - Changan Ver 
Botanical name :  Azima tetracantha 
Family  :  Salvadoraceae 
g-c   :  ,iy. Nth;> ghy; 
Rit   : ifg;G>  
jd;ik   : ntg;gk;  
gphpT    : fhh;g;G 
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nra;if: 
 rpWePh;g;nUgUf;fp  %j;jputh;j;jpdp  Diuretic 
 ntg;gKz;lhf;fp  c\;zfhhp   Stimulant 
 Jth;g;gp   ]q;Nfhrdfhhp  Astringent 
 cukhf;fp   gyfhhp   Tonic 
 Kiwntg;gfw;wp  KiwtpahjpNuhjp  antiperiodic 
 Nfhioafw;wp  fg`ufhhp   Expectorant 
Chemical constituents 
3-hexanol, 4-methyl 
Acetamide, n-2-propenyl 
2-Hexanone 
Acetic acid, butyl ester 
1-heptene 
Hexylene glycol 
Benzaldehyde 
Fzk;: 
  tPf;fk; fug;ghd; tpjhfk; fpue;jpFd;kk; 
  Cf;fkpU #iytha; NthLgpj;jj;-jhf;Ftplk; 
  tPwNkh fz;Jyq;Fk; tPRgrp uj;jKz;lhk; 
  $Wrq;fk; Nthpiy fl;F. 
 
<r;Ru%yp Nth; - Echchura-muli Ver 
Botanical name :  Aristolochia indica 
Family name  :  Aristolochiaceae  
g-c   :  ,iy> Nth; 
Rit   :  ifg;G 
jd;ik   :  ntg;gk;>  
gphpT    :  fhh;g;G 
nra;if: 
  ntg;gKz;lhf;fp  c\;zfhhp  Stimulant 
  cukhf;fp   gyfhhp  Tonic 
  UJcz;lhf;fp  UJth;j;jpdp  Emmenagogue 
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Chemical constituents 
Aristolochic acid 
Aristolactone 
Aristochene 
Ishwarol 
Ishwarane 
  ngUke;jpd; Nth;gpj;jk; gPwpiug;G fhrk; 
  tURuk; clk;Gtyp thjk; - cUTtp\k; 
  xd;wpa kfhbfs; xl;Lk cyfpypJ 
  md;wpaJ Nfhr;rpfpr;irf; fhk;. 
Mthiu Nth;: Aavarai Ver 
Botanical name: Cassia auriculata  Family : fabaceae 
gad;gLk; cWg;G: Nth;> ,iy> gl;il> tpij> Nth;> G+ 
Rit: Jth;g;G>    jd;ik: jl;gk;>    gphpT: ,dpg;G 
nra;if: 
 kykpsf;fp  yFtpNurpdp  Laxative 
 twl;rpafw;wp  ];epf;jfhhp  Emollient 
 clw;Nww;wp  tpajhNgjfhhp Alternative 
Chemical constituents 
Ethyl carpylate 
Benzoic acid, 2-hydroxy, methyl ester 
Resorcinol 
Capric acid ethyl ester 
Dodecanoic acid 
Fzk;: 
nrhy;Yjw;F kl;Nlh njhiyahj NkfePh; 
  vy;yh nkhopf;F nkhptfw;W - nky;ytr 
  khthiug; gk;guk;Ngh yhl;Le; njhopyzq;Nf! 
  ahthiu %yp aJ.   
(Nj.F.) 
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neUQ;rpy; Nth; - Nerunjil Ver 
Botanical name:Tribulus terrestris,   Family name: Zygophyllaceae 
gad;gLk; cWg;G:  r%yk;     Rit: Jth;g;G     
   jd;ik: rPjk; gphpT: ,dpg;G 
nra;if: 
 Fsph;r;rpAz;lhf;fp  rPjsfhhp   Refrigerant 
 rpWePh;g;ngUf;fp  %j;jputh;j;jpdp  Diuretic 
 cs;soyhw;wp  me;jh;];epf;jfhhp  Demuicent 
 cukhf;fp   gyfhhp   Tonic 
 Mz;ikg;ngUf;fp  fhkth;j;jpdp   Aphrodisiac 
 Jth;g;gp   ]q;Nfhrdrhhp  Astringent 
Chemical constituents 
 Glucopyranosyl Galactopyrans 
 Ruscogenin  Hecogenin 
 Titogenin  Protodioscin 
 Diosgenin  Sitosterol 
 Camphesterrol 
Fzk;: 
  ey;y neUQ;rpyJ ehSq;fp hpr;rhuj;ij 
  ty;y Rukdiy khw;Wq;fhz; - nky;ypaNy! 
  khepyj;jpy; fy;yilg;Gk; thq;fhj ePh;f;fl;Lk; 
  $DWnka; thjKk;Nghf; Fk;. 
  Nkf ntl;il ePh;r;RWf;F tPWjphp Njhlk;Gz; 
  NtfhRu jhfntg;gk; tpl;nlhopAk; - Nghfe; 
  jUQ;rpd kjiynkhopj; ijaNy! ey;y 
  neUQ;rp yjid epid.  
nrhy;nyhz;zh ePh;f;fl;L Jd;kh kprkUfy; 
  fy;yilg;ng Dk;gpzpfs; fz;lf;fhy;-ty;yf; 
  fUQ;rpdNtw; fz;khNj! fhrpdpf;Fs; ey;y 
          neUQ;rpeWk; tpj;ij epid.  
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ej;ijr;#hp Nth; - Naththai - churi ver 
Botanical name : Spermacoce hispida,   Family: Rubiaceae 
g-c : tpij> Nth;. 
Rit  : ,dpg;G> Jth;g;G>  
jd;ik : jl;gk;  
gphpT : ,dpg;G 
 
nra;if: 
Nth;: 
 clw;Nww;wp  tpahjhNgjfhhp Alterative 
 cukhf;fp  gyfhhp  Tonic 
tpij: 
 Fsph;r;rpAz;lhf;fp rPjsfhhp  Cooling 
 cs;soyhw;wp me;jh;];epf;jfhhp Demulcent 
Chemical constituents 
 Borrecarpine 
 Borrecaxine 
 Borreline 
 Isoborreverine 
 Asperuloside 
 Asperulosidic acid 
 Verticillatine A 
 Verticillatine B 
  rj;jpakha;r; nrhy;YfpNwd; 
  ej;ijr;#hp 
  jhuzpf;Fs; rhgkpy;iy nghpNahh; 
  nfhs;thh; 
  rpj;jpnad;w vl;Lkpjw; Fs;Nsahr;R 
  nrfnky;yhk; ,jd; ngUik jpwNkh 
  fhzhh; 
  Rj;jpnad;w #hpjidj; jpdKq; nfhz;lhy; 
  nrhy;ynthz;zh Mr;rhpak; 
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  ,WJe;Njfk;   
  Rj;jpnad;w mUf;fdpNy fhg;Gfl;br; 
  nrhy;ylh ke;jpuj;ijr; #l;LfpNwNd. 
  #l;LfpNwd; Xk;tr;rpu &gp#hp 
  #hp kfhtPhp Rthfh ntd;W 
  ehl;LfpNwd; r%yNk gpLq;fp te;J 
  ed;whfr; #uzk; nra;rPdpNeNu 
  Cl;LfpNwd; fye;J kz; 
  lye;jhe;jpd;D 
  xU E}W ,UgJ Nkh nthUehSk; 
  khl;LfpNwd; gj;jpuj;ij thapypl;L 
  ike;jNd kiyfnsy;yhk; 
  NehUf;fyhNk. 
  nehWf;fyhk; tpiunaLj;Jj; jpdKk; 
  nfhz;lhy; 
  E}W}op msTtiu ,Uf;fyhFk; 
  NehUf;fyhk; ve;nje;jj; 
  njhopy;fs;jhDk; 
  Nehf;fhNj kw;WnkhU fw;gNkDk; 
  nehWf;fyhQ; rj;JUTk; 
  tpahjpjhDk; 
  EZf;fNk cyfj;Njhh; fhzhug;gh 
  nehWf;fyhk; ,k;%yp rpurpy; itf;f 
  Nehf;fhNj Njtijfs; Nghw;Wk;NghNu 
     -f&T+uhh; gyjpul;L 
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nts;Ss;sp - Vellulli 
Botanical name :  Allium sativum.Linn 
Family name  :  Liliaceae 
g-c   :  fpoq;F 
Rit   :  fhh;g;G 
jd;ik   : ntg;gk;  
gphpT    : fhh;g;G 
 
nra;if: 
nfl;Ltha;tfw;wp cjuthj`ufhhp Carminative 
rpj;jPj;J}z;b [luhf;dpth;j;jpdp Stomachic 
cukhf;fp gyfhhp Tonic 
clw;Nww;wp tpajhNgjfhhp Alterative 
ntg;gKz;lhf;fp c\;zfhhp Stimulant 
Nfhioafw;wp Rg`ufhhp Expectorant 
rpWePh;g;ngUf;fp %j;jputh;j;jpdp Diretic 
GOf;nfhy;yp fpUkpehrpdp Anthelmintic 
Chemical constituents 
 Allicin 
 Alliin 
 Allixin  
 Methyl allyl disulfide 
 1,2-vinyldiithin 
 S-allyl-cysteine. 
Fzk;: 
rd;dpnahL thje; jiyNehT jhs;typ 
  kd;dptU ePh;f;Nfhit td;rPjk;-md;dNk 
  cs;Ss;sp fz;gha; cis%y NuhfKk; Nghk; 
  nts;Ss;sp jd;dhy; ntUz;L  (m.F.) 
  nts;isg;G+z;L 
  nts;Sspj; jphpfwp Nkw;ifahe; jfiuap 
  Ys;snyhd; We;jpd Tg;gr Neha;nfLk;     
      (Njud; - fhg;gpak;) 
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trk;G : Vasambu 
Botanical Name: Acorus Calamus   Family: Acoraceae 
gad;gLk; cWg;G: Nth;  Rit  - fhh;g;G>  jd;ik - ntg;gk;>  
gphpT - fhh;g;G  
nra;if:  ntg;gk; cz;lhf;fp  c~;zfhhp    stimulant 
  grpj;jPJ}z;;b   [luhf;fpdpth;j;jpdp  stomachic 
  Kiwntg;gfw;wp  KiwtpahjpNuhjp     Antiperiodic 
Chemical constituents 
 Calamen 
 Calamenol 
 Calameon 
 Asarone 
 Sesquiterpenes 
 Eugenol 
 Pinene  
 Camphene 
 Isoeugenol methyl ether 
Fzk;: 
 ghk;ghjp eQ;rw; Gjg;Gz; typtplghfq; Fd;kk; 
 #k;gh hpuj;jbj; jk;Kf ehw;wk;td; #iyrd;dp 
 tPk;ghk;ig fhrk; gPyPfQ; rypgjk; tPwpUky; 
 jhk;ghq; fpUkp gpitNaF khrpt rk;gpidNa 
 
Mkzf;nfz;nza; 
Botanical name :  Ricinus communis 
Family  :  Euphorbiaceae 
g.c.   :  ,iy> Nth;> tpj;J 
Rit   : ifg;G  
jd;ik   : ntg;gk; 
gphpT    : fhh;g;G 
 
nra;if: 
 ghw;ngUf;fp  \Puth;j;jpdp  Galactagogue 
 thjklf;fp  thj`ufhhp  Anti-vata 
105 
 
Chemical constituents 
 Ricintryglyceride 
 3-acetoxyl-acid 
 Stigmasterol 
 Ricinine 
 Methyl-3-dihydroxy benzoate 
 Gallic acid 
 Aleuritic acid 
 Lupeol. 
 
Fzk;: 
ed;ikiaf; nfhLf;ff;$bajhFk;. 
Mkzf;F nea;ahy; eyKz;lhk; ahth;f;Fk; 
G+kzf;F Nkdp Ghp#oNy-tha;kzf;ff; 
nfhs;spy; tapWtpLq; NfhuKs;s thAtWk; 
cs;spy;tU Fd;kk;Ngh NkhJ. 
mk;nghdpw Kk;tpe;J khq;Flyp Ndw;wkWk; 
Ik;nghwpr; #nlhpT khWq;fhz; - mk;Gtpapw; 
ghkzf;F kpd;gnkhopg; ghtha;! eyQ;nrwpe;j 
Mkzf;F nea;ia mUe;J 
Mkzf; nfz;nza; jd;id azpepy kwpaf; Nfz;kpd; 
G+kzr; re;JNjhWk; nghUe;jpa thjk; Nghf;Fk; 
jPke;je; jhDk; Nghf;Fe; jpfo;Tld; tpiuT Kz;lhk; 
jPkdf; Flypy; thjQ; Nrh;Fl Nyw;wk; NghNk 
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BIOCHEMICAL ANALYSIS OF KUKKILADHI CHOORNAM 
METHODOLOGY  
5gms of the drug was weighed accurately and placed in a 250ml clean beaker then 
50ml of distilled water is added and dissolved well. Then it is boiled well for about 10 
minutes. It is cooled and filtered in a 100ml volumetric flask and then it is made to 100ml 
with distilled water. The fluid is taken for analysis. 
 
QUALITATIVE ANALYSIS: 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1 
TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean test 
tube. To this add 2ml of 4% 
Ammonium oxalate solution 
A white precipitate is 
formed 
Indicates the 
presence of 
calcium 
 
2 
TEST FOR SULPHATE 
2ml of the extract is added to 
5% Barium chloride solution 
A white precipate is 
formed 
Indicates the 
presence of 
sulphate 
3 
TEST FOR CHLORIDE 
The extract is treated with 
silver nitrate 
A white precipate is 
formed 
Indicates the 
presence of 
chloride 
4 
TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl 
No brisk effervessence 
is formed 
Absence of 
carbonate 
5 
TEST FOR STARCH 
The extract is added with 
weak iodine solution 
Blue colour is formed 
Indicates the 
presence of starch 
6 
TEST FOR FERRIC IRON  
The extract is acidified with 
Glacial acetic acid and 
potassium ferro cyanide 
No blue colour is 
formed 
Absence of ferric 
iron 
7 
TEST FOR FERROUS IRON 
The extract is treated with 
concentrated Nitric acid and 
Ammonium thiocyanate 
solution 
Blood red colour is 
formed 
Indicates the 
presence of ferrous 
iron 
8 
TEST FOR PHOSPHATE 
The extract is treated with 
Ammonium Molybdate and 
concentrated nitric acid 
No yellow precipitate is 
formed 
Absence of 
phosphate 
9 
TEST FOR ALBUMIN 
The extract is treated with 
No yellow precipitate is 
formed 
Absence of 
albumin 
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Esbach’s reagent 
10 TEST FOR TANNIC ACID 
No blue black 
precipitate is formed 
Absence of tannic 
acid 
 
11 
TEST FOR 
UNSATURATION 
Potassium permanganate 
solution  is added to the 
extract 
It gets decolourised 
Indicates the 
presence of 
unsaturated 
compound 
12 
TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed toboil for 2 
minutes and add 8-10 drops of 
the extract and again boil it for 
2 minutes 
No colour change 
occurs 
Absence of 
reducing sugar 
13 
TEST FOR AMINO ACID 
One or two drops of the 
extract is placed on a filter 
paper and dried well. After 
drying,1% Ninhydrin is 
sprayed over the same and 
dried it well. 
No violet colour is 
formed 
Absence of amino 
acid 
14 
TEST FOR ZINC 
The extract is treated with 
potassium ferro cyanide 
No white precipitate is 
formed 
Absence of zinc 
 
RESULTS AND DISCUSSION: 
The trial drug Kukkiladhi choornam contains  
1. Calcium  
 2. Starch  
3. Chloride  
4. Sulphate 
 5. Ferrous iron  
6. Unsaturated compound 
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FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) ANALYSIS ON 
KUKKILADHI CHOORANAM 
 
 
FTIR SPECTRUM ANALYSIS 
Fourier transform infrared spectroscopy it is an important and more advanced technique. 
It is used to identify the functional group to determine the quality and consistency of the 
sample material and can determine the amount of compound present in the sample. 
In FTIR - infrared is passed from a source through a sample. This infrared is absorbed by 
the sample according to the chemical properties and some are transmitted. The spectrum 
that appears denotes the molecular absorption and transmission. It forms the molecular 
finger print of the sample. It is recorded as wavelength and the peaks seen in the spectrum 
indicate the amount of material present 
 
                   FIGURE: 1 
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INTERPRETATION 
TABLE: 1 
S.NO WAVE NUMBER 
VIBRATIONAL MODES 
OF KUKKILADHI 
CHOORNAM 
FUNCTIONAL 
GROUP 
1. 3832.56 ---- Unknown compound 
2. 3008.95 O-H stretching alcohol 
3. 2427.94 C-H stretching alkanes 
4. 2854.65 C-H stretching alkanes 
5. 2358.94 C=N stretching nitrates 
6. 1708.93 C=O stretching 
Dimer(carboxylic 
acid) 
7. 1653.00 C=N stretching Imine/oxime 
8. 1450.47 C=H bending alkane 
9. 1249.87 C-N stretching amine 
10. 1157.29 C-O stretching Tertiary alcohol 
11. 1082.07 C-O stretching Primary alcohol 
12. 1039.62 S=O stretching sulfoxide 
13. 860.25 C-H bending aromatics 
14. 763.81 C-Cl stretching Alkyl halides 
15. 711.73 C-H stretching aromatics 
16. 613.36 C-Br stretching Halo compound 
17. 576.72 C-Br stretching Halo compound 
18. 530.42 C-Br stretching Halo compound 
19. 435.91 C-X stretching Bromide/iodide 
 
 RESULTS 
In FTIR spectre analysis, this sample analysis Kukkiladhi chooranam exhibit the peak 
value at 3832.56, 3008.95, 2427.94, 2854.65, 2358.94, 1708.93 1653.00, 1450.47, 
1249.87,                                  1157.29,  1082.07,   1039.62,  860.25, 763.817, 711.73, 
613.36, 576.72,530.42, 435.91 having C-H stretching, O-H stretching, C=N stretching, 
C=O stretching, C-O stretching, C-N stretching, S=O stretching, C-Cl stretching, C-Br 
stretching, C-X stretching.      
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   This indicates the presence of some organic functional groups such as alcohol, alkanes, 
imine/oxime, tertiary alcohol, primary alcohol, sulfoxide, aromatics, alkyl halides, halo 
compound, bromide/iodide. The presence of alkanes protects against bacteria and fungal 
infections. The presence of aromatics are good pain relievers has anti-pyretic, anti-
inflammatory auto-immune activities. The presence of alcohol has an anti microbial 
action. Acts as an antiseptic agent. 
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ANTI-INFLAMMATORY ACTIVITYOF KUKKILADHI CHOORANAM 
 
The anti-inflammatory activities of Kukkiladhi chooranam at 100 mg/kg and 
200mg/kg doses were evaluated using carrageenan-induced paw edema method. The 
inflammation was readily produced in the form of edema with the help of irritant such as 
carrageenan. Carrageenan is a sulphated polysaccharide obtained from sea weed 
(Rhodophyceae) and when injected cause the release of prostaglandins by the way it 
produces inflammation and edema. 
REQUIREMENTS: 
Animal                                : Albino rat (180-200 g) 
Drugs and chemicals          : Carrageenan (1%w/v), Diclofenac sodium (standard), 
Carboxy methyl cellulose (1%w/v), 
Plethysmo meter. 
Test compound                :  kukkiladhi chooranam 
METHOD: 
Anti-inflammatory activity was performed by the following procedure. The animals were 
divided into 4 groups each having six animals. A freshly prepared suspension of 
carrageenan (1% w/v, 0.1 ml) was injected to the planter region of left hind paw of each 
rat. One group was kept as control and the animals of the other groups were pretreated 
with the kukkiladhi chooranam test Compounds dissolved with 2 ml sterile water given 
through orally 30 min before the carrageenan treatment. The paw volumes of the test 
compounds, standard and control groups were measured at 60,240,360 minutes of 
carrageenan treatment with the help of plethysmometer . Mean increase in paw volume 
was measured and the percentage of inhibition was calculated. 
% Anti-inflammatory activity = (Vc-Vt / Vc) x 100 
Where, Vt-mean increase in paw volume in rats treated with test compounds, 
Vc-mean increase in paw volume in control group of rats. 
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TABLE No.1 
ANTI-INFLAMMATORY ACTIVITY OF KUKKILADHI CHOORANAM 
Treatment Dose (mg/kg) 
Paw volume(ml) 
as measured by 
mercury 
displacement at 6 
hour 
Percentage 
inhibition of paw 
edema 
Group I 
Normal saline 
10ml/kg orally 4.20±0.96 - 
Group II 
Std 
10mg/kg 
I.P.Diclofenac 
sodium 
0.70±0.40 83.33%*a 
Group III 
KUKKILADHI 
CHOORANAM 
100/kg.Orally. 1.06±0.48 74.76%*a 
Group IV 
KUKKILADHI 
CHOORANAM 
200mg/kg.Orally.  0.90±0.52 78.57%*a 
 
* Data are expressed as Mean ± S.E.M. 
*Data were analyzed by one way ANOVA followed by Newman’s keul’s multiple range 
tests, to determine the significance of the difference between the control group and rats 
treated with the test compounds. 
*a   Values were significantly different from normal control at P< 0.01. 
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Results 
Anti- inflammatory activity 
Both extracts of Kukkiladhi chooranam at doses 100mg/kg and 200mg/kg were 
tested for their Anti- inflammatory activity by using carrageenan Induced rat paw 
edema method and the results are tabulated in table no 1.  The results reveals that   
both extracts of Kukkiladhi chooranam  at 100mg/kg and 200mg/kg doses 
possesses significant Anti- inflammatory activity when compared to control group 
at p<0.01. 
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ANTI HISTAMINE ACTIVITY OF KUKKILADHI CHOORANAM 
 
Experimental Animals 
Wister rats (175-200 g) of either sex housed in standard conditions of temperature (22 ± 
2°C), relative humidity (55 ± 5%) and light (12 hrs light/dark cycles) were used. They 
were fed with standard pellet diet and water ad libitum. The experimental protocol was 
approved by Institutional Animal Ethical Committee as per the guidance of CPCSEA,  
Histamine and acetylcholine induced bronchospasm in rats 
Rats of either sex were divided into two groups of six animals each and exposed to 0.1% 
w/v of histamine dihydrochloride aerosol in histamine chamber. The progressive dyspnea 
was observed in animals when exposed to histamine aerosol. The end point, 
preconvulsion dyspnea (PCD) was determined from the time of aerosol exposure to the 
onset of dyspnoea leading to the appearance of convulsion. As soon as PCD commenced, 
the animals were removed from chamber and placed in fresh air. PCD of this time was 
taken as day 0 value. Both groups of rats were given KC at the dose of 100 mg/kg, and 
200 mg/kg, p.o. respectively, once a day for 7 days. On the 7 day 2 h after the last dose, 
the time for the onset of PCD was recorded as on day 0. Same procedure was followed in 
another set of animals (n = 6) for acetylcholine induce bronchospasm study using 0.5% 
acetylcholine chloride. The percentage increased in time of PCD was calculated using 
following formula. 
Percentage increased in time of PCD = (1-T1/T2) × 100 
where T = time for PCD onset on day 0, T = time for PCD onset on day 7 
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PRECONVULSIVE DYSPNEA (SEC) 
Treated 
group 
Arachidonic acid – induced 
bronchospasm 
Acetylcholine – induced 
Bronchospasm 
 
KC 
Before 
treatment 
(control) 
After 
treatment 
% 
increase 
Before 
treatment 
(control) 
After 
treatment 
% 
increase 
100 
mg/kg, 
p.o 
 
105.60 ± 2.30 
282.42 ± 
3.11* 
 
62.60 
 
 
145.06 ± 1.12 
202.20 ± 
2.06* 
 
28.25 
200 
mg/kg, 
p.o 
 
115.01 ± 1.88 
530.01 ± 
4.52* 
 
78.30 
 
136.02 ± 0.20 
252.02 ± 
3.06* 
 
46.06 
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Mast Cell Degranulation Studies. 
 
Albino rats of either sex were divided into 4 groups of six animals each and 
sacrificed by cervical dislocation. The animals were immediately injected with 15 ml of 
prewarmed (37°C) buffered salt solution (NaCl 137 mM; KCl 2.7 mM; MgCl2; 1 mM; 
CaCl2 0.5 mM; NaH2PO4 0.4 mM; Glucose 5.6 mM; HEPES 10 mM) into the peritoneal 
cavity, and massaged gently in this region for 90 s, to facilitate cell recovery. A midline 
incision was made and the peritoneum was exposed. The pale fluid was aspirated using a 
blunted plastic Pasteur pipette, and collected in a plastic centrifuge tube. The fluid was 
then centrifuged at 1000 rpm for 5 min, and the supernatant was discarded to reveal a pale 
cell pellet. The cell pellets were resuspended in fresh buffer and recentrifuged. 
 
The peritoneal cell suspension divided in 4 parts viz. – ve control, +ve control, 
reference standard (s.c  0.5mg/kg) and KC at different concentration i.e., 100, 200,mg/kg, 
each containing 0.1 ml of cell suspension and incubated at constant temperature 37°C in 
water bath for 15 min. Then 0.1 ml of compound 48/80 was added in all samples except 
in – ve control group and suspensions were further incubated for 10 min at 37°C. The 
cells were then stained with 10% of toludine blue solution and observed under the higher 
magnification by microscope. The percent granulated and degranulated mast cells were 
counted in each group. 
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MAST CELL PERCENTAGE 
Group Treatment Intact Disrupted % Protection 
1 Distilled water (10 
ml/kg, p.o) 
23.7 ± 0.45 86.3 ± 0.45 - 
 
2 
Sodium cromoglycate 
(0.5mg/kg, i.p) 
 
73.20 ± 6.25** 
 
26.80 ± 6.25** 
 
86.03 
3 KC – (100mg/kg, p.o) 49.02 ± 0.23** 50.98 ± 0.23** 50.71 
4 KC– (200 
mg/kg, p.o) 
40.05 ± 50.01** 59.95 ± 50.01** 59.68 
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ACUTE ANTI-INFLAMMATORY STUDY ON KARAPPANUK ENNAI 
(External) 
BY HINDPAW METHOD IN ALBINO RATS 
 
Procedure: 
Anti-inflammatory study of karappanuku ennai was studied in healthy albino rats. 
Six rats were selected and divided in to three groups. To the first group distilled 
water was given and kept as control. The second group was given the standard drug 
diclofenac at a dose of 5 mg/kg body weight. The third group was treat with the test drug 
extermelly.Before the application of the drug the kind paw volume of all rats was 
measure .This was done by dipping the kind paw upto the tibio dorsal junction in a 
mercury plethysmography. Subcutaneous injection of 0.1 ml of 1%w/v carrageenin in 
water was made in to planter surface of both the kind paw of each rat.  
Three hours after injection the kind paw volume was measured once again. The 
difference between the initial and final volume would show the amount of inflammation. 
Taking the volume in the control group as 100% of inflammation the 
inflammatory or anti-inflammatory effect of the test group is calculated, injection of 0.1 
ml of 1%w/v of carrageenin in water was made into planter surface of both the hind paw 
if each rat. 
Three hours after carrageenin injection, the hind paw volume was measured once 
again. Difference between the initial and final value were noted and compared. 
The method is more suitable for studying anti-inflammatory activity on acute 
inflammation. 
The result of the drug is compared with the standard as well as control group. 
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 Study of Acute –Inflammatory By Hind Paw Method 
 
Serial 
no 
Name of 
drugs/groups 
Dose/100 
gram 
body 
weight 
Initial 
reading 
average 
final 
reading 
average 
Mean 
difference 
Percentage 
inflammation 
Percentage 
inhibition 
1 Water 2 ml 0.8 1.6 - 100 - 
2 Diclofenac 5 mg/kg 0.8 0.9 0.1 11.1 88.9 
3 Karappanukennai  0.9 1.1 0.2 18.1 81.9 
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TOXICITY STUDIES 
EVALUATION OF ACUTE TOXICITY STUDY OF  
Effect of Acute Toxicity Study (14 Days) of KUKKILATHI CHOORANAM 
Table no –1   Physical and behavioral examinations. 
Group 
no. 
Dose(mg/kg) Observation sign No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
Table no-2    Home cage activity 
Function
al and 
Behavio
ural 
observati
on 
Observat
ion 
5mg/
kg 
Grou
p 
(G-I) 
50mg/
kg 
(G-II) 
300mg/
kg 
(G-III) 
 
1000mg
/kg 
(G-IV) 
2000mg
/kg 
(G-V) 
Fem
ale 
n=3 
Femal
e n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body 
position 
Normal 3 3 3 3 3 
Respirati
on 
Normal 3 3 3 3 3 
Clonic 
involunta
ry 
Moveme
nt 
Normal 3 3 3 3 3 
Tonic 
involunta
ry 
Moveme
nt 
Normal 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 
Approach 
response 
Normal 3 3 3 3 3 
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Table no-3  Hand  held  observation 
Function
al and 
Behavior
al 
observati
on 
Observ
ation 
Con
trol 
5 
mg/ 
kg 
(G-
I) 
50 
mg/
kg 
(G-
II) 
300m
g/kg 
(G-
III) 
1000m
g/kg 
(G-IV) 
2000m
g/kg 
(G-V) 
Fem
ale 
n=3 
Fem
ale 
n=3 
Fem
ale 
n=3 
Fema
le n=3 
Femal
e n=3 
Femal
e n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure 
Normal 3 3 3 3 3 3 
Lacrimati
on 
Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerecti
on 
Normal 3 3 3 3 3 3 
Pupillary 
reflex 
Normal 3 3 3 3 3 3 
Abdomina
l tone 
Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
 
 
 
 
 
 
 
 
 
Touch 
response 
Normal 3 3 3 3 3 
Pinna 
reflex 
Normal 3 3 3 3 3 
Tail 
pinch 
response 
Normal 3 3 3 3 3 
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DISCUSSION 
  KUKKILATHI CHOORANAM was administered single time at the dose of 
5mg/kg, 50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot study 
and literature review. All animals were observed daily once for any abnormal clinical 
signs. Weekly body weight and food consumption were recorded. No mortality was 
observed during the entire period of the study. Data obtained in this study indicated no 
significance physical and behavioural signs of any toxicity due to administration of 
KUKKILATHI CHOORANAM at the doses of 5mg/kg, 50mg/kg , 300mg/kg, 
1000mg/kg and 2000mg/kg to rats.  
  At the 14th day, all animals were observed for functional and behavioral 
examination. In functional and behavioral examination, home cage activity, hand held 
activity were observed. Home cage activities like Body position, Respiration, Clonic 
involuntary movement, Tonic involuntary movement, Palpebral closure, Approach 
response, Touch response, Pinna reflex, Sound responses, Tail pinch response were 
observed. Handheld activities like Reactivity, Handling, Palpebral closure, 
Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominaltone, Limb tone were 
observed. Functional and behavioral examination was normal in all treated 
groups.Food consumption of all treated animals was found normal as compared to 
normalgroup. 
  Body weight at weekly interval was measured to find out the effect of 
KUKKILATHI CHOORANAM on the growth rate. Body weight change in drug 
treated animals was found normal. 
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Table no-4   Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
RESULT: 
  From acute toxicity study it was observed that the administration of 
KUKKILATHI CHOORANAM at a dose of 2000 mg/kg to the rats do not produce drug-
related toxicity and mortality. So No-Observed-Adverse-Effect- Level (NOAEL) of 
KUKKILATHI CHOORANAM is 2000 mg/kg.  
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SUB-ACUTE TOXICITY STUDY IN WISTAR RATS TO EVALUATE 
TOXICITY PROFILE OF KUKKILATHI CHOORANAM 
Table :5 EFFECT OF SUB- ACUTE DOSE (28 DAYS)OF KUKKILATHI 
CHOORANAM ON BODY WEIGHT IN GRAM 
GROUP CONTROL LOW  MID HIGH 
1
st
 day 119.3±1.03 122±1.543 121.3±2.231 123.3±2.23 
7
th
 day 129.3±1.03 128.3±1.343 128±2.113 134±2.11 
14
th
 day 131.1±1.004 100.3±1.12 100.4±2.012 100.4±2.012 
21
st
 day 100.3±2.120 108.2±1.501 101±1.131 102±1.13 
28
th
 day 110.3±1.041 109.3±1.202 140±2.0405 143±2.040 
 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group. 
 
 
 
EFFECT OF SUBACUTE DOSE (28 DAYS) OF KUKKILATHI CHOORANAM 
Table : 6 KUKKILADHI CHOORANAM ON ORGAN WEIGHT (PHYSICAL 
PARAMETER) IN GRAM 
GROUP CONTROL LOW  MID HIGH 
HEART 0.43±0.02 0.41±0.04 0.41±0.11 0.41±0.02 
LIVER 2.01± 0.23 2.03±0.23 2.17±0.01 2.20± 0.23 
LUNGS 1.01±0.10 1.01±0.14 1.20±0.24 1.13±0.10 
KIDNEY L 0.93±0.02 1.22±0.03 0.83±0.02 0.71±0.02 
 R 0.91±0.024 1.11±0.02 0.81±0.024 0.62±0.024 
 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
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EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KUKKILATHI CHOORANAM 
ON HAEMATOLOGICAL PARAMETERS 
Table no 7 
 
Drug 
treatm
ent 
RBC 
million 
cells/c
mm 
WBC  
cells/cmm 
Haemoglob
ingm % 
Differen
tial 
count 
% 
   
    Neutop
hils 
Eosinop
hils 
Monoc
yte 
Limpho
cyte 
Contro
l 
5.18±0.
40 
5249.41±2
3.32 
12.40±0.45 58.27±1.
20 
1.23±0.1
1 
3.15±0.
15 
20.13±3.
32 
LOW  4.37±0.
20 
4330.04±2
3.22 
11.20±0.43 52.54±1.
41 
3.07±0.1
4 
4.09±0.
30 
30.22±3.
51 
MID 4.03±0.
21 
4301.25±3
2.35 
11.11±1.03 57.32±2.
22 
4.14±0.1
2 
3.02±0.
40 
30.13±3.
32 
HIGH 5.06±0.
21 
5685.25±3
2.35 
13.11±1.03 45.32±2.
22 
2.20±0.1
2 
3.04±0.
40 
21.13±3.
32 
 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one way 
ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
        
        
Table :8  EFFECT OF SUB- ACUTE DOSE(28 DAYS)OF KUKKILATHI 
CHOORANAM ON BIOCHEMICAL PARAMETERS 
 
Drug 
Treatment 
SGPT 
(IU/L) 
SGOT(U/L) ALT(IU/L) Urea 
(mg/dl) 
Creatinine(mg/dl) 
Control 19.14±3.
02 
39.24±4.31 240.12±11.3
2 
22.35±3.
00 
0.64±0.03 
      LOW 29.13±3.
22 
38.23±4.01 248.11±12.4
2 
27.53±2.
42 
0.60±0.04 
MID 27.21±4.
44 
41.31±2.21 242.45±4.14 26.12±2.
22 
0.65±0.04 
HIGH 29.21±4.
44 
37.31±2.21 231.45±4.14 27.12±2.
22 
0.76±0.04 
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Table: 9 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KUKKILATHI 
CHOORANAM BIOCHEMICAL PARAMETERS 
 
Group Control Kukkilathi 
chooranam(200mg/k
g) 
Kukkilath
i 
choorana
m 
(400mg/k
g) 
Kukkilath
i 
choorana
m 
(600mg/k
g 
TOTAL 
BILIRUBI
N (mg/dl) 
1.08±0.5
7 
1.0±0.27 0.88±0.76 0.97±0.19 
  
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-way 
ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group.  
 
 
Table:10  EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF KUKKILATHI 
CHOORANAM ON FOOD INTAKE IN GRAM 
 
GROUP CONTROL low Mid high 
1
st 
DAY 15.33±13.5110 16.1672±14.3 09.10±21.71 14.5±7.62 
7
th 
DAY 12.5±11. 07.863±12.67 13.73±9.853 08.17±14.41 
14
th 
DAY 15.83±8.72 07.83±14.28 09±13.96 16.72±8.981 
21
st DAY
 08.87±12.4 12±8.466 12.88±9.43 16.17±8.02 
28
th
 DAY 09.10±11.38 15.38±11.50 09±8.90 07±7.57 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-way 
ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group 
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Table:11. Effect of Sub- Acute Dose (28 Days) Of  KUKKILATHI CHOORANAM 
On Water Intake in ml 
gro
up 
control kukkilathi 
chooranam(200
mg/kg) 
kukkilathi 
chooranam(400
mg/kg) 
kukkilathi 
chooranam(600
mg/kg) 
1
st 
DA
Y 
96.38±1
3.10 89.72±14.26 102.10±21.99 67.5±7.63 
7
th 
DA
Y 
85.5±11
.38 100.83±12.70 76.63±9.63 81.17±14.0 
14
th 
DA
Y 
58.83±8
.17 90.63±14.2 80±13 89.72±8.81 
21
st 
DAY
 
91.67±1
2.49 85±8.462 65.38±9.50 89.17±8.72 
28
th
 
DA
Y 
82.10±1
1.40 88.348±11.04 80±89.01 70±7.573 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-way 
ANOVA followed by Dennett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001, 
calculated by comparing treated groupswith control group 
Table: 12  EFFECT OF SUB ACUTE DOSES (28 DAY) OF KUKKILATHI 
CHOORANAMON ELECTROLYTES: - 
 
Values are expressed as mean ± SEM Statisticalsignificance (p) calculated by one-way 
ANOVA followed by Dennett’s(n=6); NS- non-significant, *p<0.05**p<0.01, 
***p<0.001,  
 
Group Control 
Kukkilathi 
chooranam 
(200mg/kg) 
Kukkilathi 
chooranam 
(400mg/kg) 
Kukkilathi 
chooranam 
(600mg/kg) 
Sodium (mg/dl) 
150±0.7 143±0.92 141±0.71 142.80±0.70 
Calcium(mg/dl) 10.80±0.179 13.20±0.13* 14.7±0.19* 16.180±0.19** 
Phosphorus 
(U/L) 4.8.8±0.27 6.30±0.015
ns 
4.30±0.01
ns 
5.7±0.32* 
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6.0 RESULTS 
CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the dosing   period 
of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived throughout the dosing 
period of 28 days. 
 Body weight: 
Results of body weight determination of animals from control and different dose 
groups exhibited comparable body weight gain throughout the dosing period of 28 
days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food consumed by 
animals from different dose groups was found to be comparable with that by control 
animals. 
Organ Weight: 
Group Mean Relative Organ Weights (% of body weight) are recorded in Table 
Comparison of organ weights of treated animals with respective control animals on day 
29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations conducted on day 29 revealed following 
significant changes in the values of different parameters investigated when compared 
with those of respective controls; however, the increase or decrease in the values 
obtained was within normal biological and laboratory limits or the effect was not dose 
dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on the day 29th and recorded in Table 
no 24, 25 revealed the following significant changes in the values of hepatic serum 
enzymes studied. When compared with those of respective control. However, the 
increase or decrease in the values obtained was within normal biological and laboratory 
limits. 
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INTERPRETATION: 
1)  All the animals from control and all the treated dose groups survived throughout the 
dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during the 
dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28 days 
5)   Haematological analysis conducted at the end of the dosing period on day 29th, 
revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29
th
, no 
abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was found to 
be comparable with that of respective controls. 
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DERMAL TOXICITY STUDIES 
EVALUATION OF ACUTE TOXICITY STUDY OF KUKKILADHI 
CHOORANAM 
TEST METHOD  
Preparation of the test item, The test item was applied as such onto the skin of rats. 
Test item was prepared under dark conditions. Test Procedure A range finding study 
using a male and a female rat at dose 2000 mg/Kg b.w. was carried out in order to 
establish the dose levels for the main study. Approximately, 24 hours before the 
treatment, around 10% dorsal skin area of each rat was clipped free of hair, without 
any abrasion. The appropriate amount of the test item was applied uniformly over the 
clipped area of each rat. After the application, the test item was held in contact with the 
skin for a period of 24 hours, using a porous gauze dressing (Modern Health Care, B. 
No.: 141, Expiry: October 2017) and bandaged with non-irritating adhesive tape. After 
24 hours, the residual test item was wiped gently from the skin using wet cotton, 
soaked in water. Neck collar was used to prevent the ingestion of the test item from the 
application site. No mortality was observed for 4 days in the range finding study at 
2000 mg/Kg b.w. Based on the results from the range finding experiment, limit test 
was chosen. In the limit test, 3 male and 3 female rats were exposed to 2000 mg/Kg 
b.w. 
Effect of Acute Toxicity Study (14 Days) of DM N 
Table no-1   Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
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Table :2 EFFECT OF SUB- ACUTE DOSE (28 DAYS)OF KUKKILADHI 
CHOORANAM ON BODY WEIGHT IN GRAM 
GROUP CONTROL LOW  MID HIGH 
1
st
 day 122.3±1.04 121±1.543 127.3±2.231 125.3±2.23 
7
th
 day 132.3±1.03 131.3±1.343 131±2.113 135±2.11 
14
th
 day 132.1±1.004 121.3±1.12 121.4±2.012 122.4±2.012 
21
st
 day 122.3±2.120 129.2±1.501 123±1.131 124±1.13 
28
th
 day 122.3±1.041 121.3±1.202 122±2.0405 125±2.040 
Table no-1 
SKIN 
REACTIO
N 
Obser
vation 
Con
trol 
5 
mg/ 
kg 
(G-
I) 
50 
mg/
kg 
(G-
II) 
300m
g/kg 
(G-
III) 
1000m
g/kg 
(G-IV) 
2000m
g/kg 
(G-V) 
Fem
ale 
n=3 
Fem
ale 
n=3 
Fem
ale 
n=3 
Fema
le n=3 
Femal
e n=3 
Femal
e n=3 
ERYTHEA 
Norma
l 
- - - - - - 
EDEMA 
Norma
l 
- - - - - - 
SCALING      
OF 
EPIDERMI
S 
Norma
l 
- - - - - - 
 
DISCUSSION 
  Kukkiadhi chooranam was administered single time at the dose of 5mg/kg, 
50mg/kg , 300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for consecutive 
14 days after administration. Doses were selected based on the pilot study and 
literature review. All animals were observed daily once for any abnormal clinical signs. 
Weekly body weight and food consumption were recorded. No mortality was observed 
during the entire period of the study.  
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  Body weight at weekly interval was measured to find out the effect of 
kukkiladhi chooranam on the growth rate. Body weight change in drug treated 
animals was found normal. 
 
6.0 RESULTS: 
CLINICAL SIGNS: 
All animals in this study were free of toxic clinical signs throughout the dosing   period 
of 28 days. 
 Mortality: 
All animals in control and in all the treated dose groups survived throughout the dosing 
period of 28 days. 
 Body weight: 
Results of body weight determination of animals from control and different dose 
groups exhibited comparable body weight gain throughout the dosing period of 28 
days. 
 
INTERPRETATION: 
1)  All the animals from control and all the treated dose groups up to 15ml/kg survived 
throughout the dosing period of 28 days. 
2)  No signs of toxicity were observed in animals from different dose groups during the 
dosing period of 28 days. 
3)  Animals from all the treated dose groups exhibited comparable body weight gain 
with that of controls throughout the dosing period of 28 days. 
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Antimicrobial activity of siddha herbo mineral drug kukkiladhi chooranam 
Method: 
Kirby Bauer 
 Prepared plates of Mueller Hinton Agar (M173) for in the Kirby - Bauer Method 
for rapidly growing aerobic Organisms. 
Antimicrobial test report 
S.No Drug Organism 
Susceptibility 
Sensitivity 
Zone size 
of drug 
Zone size of 
control(amikacin) 
1. 
Kukkiladhi 
chooranam 
Pseudomonas 
aeruginosae 
 
Staphylo 
coccus 
aureus 
Resistant 
 
 
Moderate 
Resistant 
-- 
 
 
09mm 
18mm 
 
 
16mm 
 
Antimicrobial studies 
To study the anti microbial action of “Kukkiladhi chooranam” against Staphylococcus 
aureus, Pseudomonas aeruginousae. 
Medium 
Muller hinton agar 
Components of medium 
Beef extract 300 gms/lit 
Agar  17 gms/lit 
Starch  1.5 gms/lit 
Casein hydrpxylate 17.5 gms/lit 
Distilled water 1000 ml 
PH 7.6 
 
 Procedure 
 The media was prepared from the above components and poured and dried on a 
petridish. The organism was streaked on the medium and the test drug (1 gm drug in 250 
ml of water) was placed on the medium. This is incubated at 37c for one over night and 
observed for the susceptibility shown up clearance around the drug. 
134 
 
 
 
137 
 
Assessment forms  
    
FORM I  :  Screening of Selection Proforma  
FORM II  :  Consent Form (Tamil and English)  
FORM III  :  History Proforma on Enrolment  
FORM IV  :  Clinical Assessment Form  
FORM V  :  Laboratory Investigations Form  
FORM VI  :  Drug Compliance Form  
FORM VII  :  Adverse Drug Reaction Form  
FORM VIII :  Withdrawal Form  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & 
HOSPITAL PALAYAMKOTTAI, TIRUNELVELI 
DISTRICT DEPARTMENT OF SIRAPPU MARUTHUVAM  
  
 AN OPEN CLINICAL STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF 
SIDDHA POLYHERBAL MEDICINE KUKKILADHI CHOORANAM [INTERNAL],  
KARAPPANUKU ENNAI [EXTERNAL] AND VETHU FOR THE TREATMENT  
OF KARAPPAN[ECZEMA]  
  
FORM-I (SCREENING AND SELECTION PROFORMA)  
  
   1. OPD/IPD No.:       2. Date:  3. SI. No.:       
4. Name:          5. Age:   6. Gender:    ___ 
7. Phone No.:        
    
INCLUSION CRITERIA:  
1.  Age between 18 – 60 years 
2. Both sex 
3. Symptoms 
. Erythema 
. Papules 
. Intense itching 
. Recurring rash 
. Scaly rash 
. Oozing 
. Hypo and hyper pigmented patches of skin 
Exclusion 
1. Psoriasis 
2. Fungal infection 
3. Scabies and other infestation 
4. Pregnancy women and lactating mothers 
5. Bedridden patient for severe illness. 
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WITHDRAWAL CRITERIA:  
Intolerance to the drug and development of adverse reactions during drug trial.
 
 
 Poor patient compliance and defaulters
 
 
 Patient turned unwilling to continue in the course of clinical trial
  
 Occurrence of any serious illness
  
           
DATE  :  
STATION  :  
       
    Signature of the Investigator  
           
  
    Signature of the Guide/HOD  
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT DEPARTMENT OF 
SIRAPPU MARUTHUVAM  
  
AN OPEN CLINICAL STUDY TO EVALUATE THE THERAPEUTIC EFFICACY 
OF  
 SIDDHA POLYHERBAL MEDICINE KUKKILADHI CHOORANAM 
[INTERNAL],  
KARAPPANUKU ENNAI [EXTERNAL] AND VETHU FOR THE TREATMENT 
OF 
KARAPPAN [ECZEMA] 
FORM-II 
CONSENT FORM 
 
Certificate by Investigator 
  
I certify that I have disclosed all details about the study in the terms readily 
understood by the  
  
Patient.  
  
Date: ……………..  
  
Signature of the  
  
Signature of the Investigator: ……………..  
  
Guide/HOD: …………………….  
  
Name: ……………………………..  
  
Name: ……………………………  
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Consent by Patient  
  I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up including 
the laboratory investigations to be performed to monitor and safeguard my body 
functions.  
  
I am aware of my right to withdraw from the trial at any time during the course of the 
trial without having to give the reasons for doing so.  
  
I, exercising my free power of choice, hereby give my consent to be included as a 
clinical trial of  KUKKILADHI CHOORANAM [INTERNAL], KARAPPANUKU 
ENNAI [EXTERNAL] AND VETHU FOR THE TREATMENT OF 
KARAPPAN[ECZEMA].  
    
 Date: ……………….. Name: ……………  Signature: …………………………………  
    
    
 Date: ……………….. Name: ………………  Signature of Witness: …………………….  
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murpdH rpj;j kUj;Jtf; fy;Yhhp kw;Wk; kUj;Jtkid 
ghisaq;Nfhl;il 
gl;l Nkw;gbg;G rpwg;G kUj;Jtj;Jiw 
 
‘Ff;fpyhjp #uzk;” kw;Wk; ‘fug;ghDf;F vz;nza;” ,tw;wpd; ghpfhpg;Gj; 
jpwidf; fz;lwpAk; kUj;Jt Ma;T xg;Gjy; gbtk; Ma;thsuhy; 
rhd;wspf;fg;gl;lJ. 
 
ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GhpAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp  :       ifnahg;gk;: 
,lk; :        ngaH: 
Nehahspapd; xg;Gjy; 
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik kw;Wk; 
kUj;Jt topKiwiag; gw;wpAk; njhlHe;J vdJ cly; ,af;fj;ij 
fz;fhzpf;fTk;> mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l 
ghpNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; 
tpsf;fpf; $wg;gl;lJ. 
 ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; nfhs;Sk; chpikia 
njhpe;jpUf;fpd;Nwd;. 
 ehd; vd;Dila Rje;jpukhfj; NjHT nra;Ak; chpikiaf; nfhz;L 
fug;ghd; vd;Dk; Neha;f;fhd Ff;fpyhjp #uzk; kw;Wk; fug;ghDf;F vz;nza;; 
Mfpatw;wpd; ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;F vd;id 
cl;gLj;j xg;Gjy; mspf;fpNwd;. 
 
Njjp :      ifnahg;gk;: 
,lk; :       ngaH :  
     
       rhl;rpf;fhuHifnahg;gk;: 
       ngaH : 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE 
THE THERAPEUTIC EFFICACY OF KUKKILATHI CHOORANAM 
[INTERNAL] AND KARAPANUKU ENNAI [EXTERNAL] WITH VETHU 
[EXTERNAL]
 
IN KARAPPAN [ECZEMA]. 
FORM III 
 
HISTORY PROFORMA ON ENROLLMENT 
1. Serial No of the case:   _______________                                         2. OPD/IPD 
No_______ 
 
3. Name: ____________                                                                 4. Gender:                          
 
5. Age (years): _________ DOB            
             
 Date       Month            Year 
 
6. Address: -------------------------------------- 
                     -------------------------------------- 
                     -------------------------------------- 
7. A. Occupation:    -----------------------------                         B. Income ----------------- 
8. Educational Status:   A) Illiterate                  B) Literate          
 
9. Height: ---------- cm                10. Weight: ----------kg 
 
11. Complaints and Duration: 
 
12. Past History                    
  Hypertension    ______________    
   Diabetes mellitus ______________   
    Asthma  ______________  
     PT   ______________ 
Other   ______________ 
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13. HABITS 
    
A) Smoking: 1. Yes                 duration ________ years:    Number - _____     2. No  
 
B) Alcoholism:1. Yes                duration ________ years:    Quantity- ____ ml 2. No  
 
C) Tobacco chewing:  1. Yes                duration ________ years        2.No  
                                     
D) Betel chewing    :  1. Yes                duration ________ years         2.No 
 
14. Dietary style:   A. Pure vegetarian                B. Non-vegetarian                C. Mixed 
diet 
 
15. Drug history: Had the patient been treated before with allopathy drug?  
 
                                A) Yes                                    2) No                                     
 
16 Marital status :   1.Married         2.Unmarried                                                  
 
17. Family history : 
Whether this problem runs in family?             1. Yes                               2.No   
  
(If yes, mention the relationship)                                                                                                                  
 18. Bowel habits & micturition:      Normal                                      Abnormal 
(Details of an abnormality)                                                             
 
 19. Psychological state:      Normal                    Anxiety                   Depression          
  
   
 
 
Signature of the Investigator                                    Signature of the Guide/HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE 
THE THERAPEUTIC EFFICACY OF KUKKILADHI CHOORANAM 
[INTERNAL] AND KARAPPANUKU ENNAI [EXTERNAL] WITH VETHU 
[EXTERNAL THERAPY]
 
IN KARAPPAN [ECZEMA]. 
FORM IV 
CLINICAL ASSESSMENT ON ENROLLMENT AND ON VISITS 
1. S.No:  _______                                                2. OPD/IPD No : __________                            
      3.  Name: _______________________              4. Gender: __________    
      5. Date of assessment: ____________  _____________ 
 SIDDHA SYSTEM OF EXAMINATION 
I. ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 Naadi: [pulse perception] 
 Naa:[tongue] 
 Niram: [complexion]    
 Mozhi: [voice] 
 Vizhi: [eyes]  
 Malam: [bowel habits / stools] 
 Moothiram: 
 Sparisam: [palpatory perception] 
 
2. THEGI: [ TYPE OF BODY CONSTITUTION]    
 
3.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
  Kurinji                   Mullai                   Marutham                    Neithal                  Palai 
(Hilly terrain)        (Forest range)        (Plains)                     (Coastal belt)        (Arid 
regions)  
 4. KAALAM: 
Kaarkalam -                                  Pinpanikalam  -    
Koothirkalam -                                    Ilavenil - 
Munpanikalam  -                          Muthuvenil - 
 
5. GUNAM: 
Sathuvam   -                      Rasatham -                         Thamasam  - 
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